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Abstract 
 
The human genetic disorder ataxia-telangiectasia (A-T) is an autosomal recessive neurodegenerative 
condition occurring in 3 per million live births. The disease is characterised by neurodegeneration, 
immunodeficiency, radiosensitivity, cell cycle checkpoint defects, genomic instability and cancer 
predisposition among patients. The most debilitating aspect of the disease is progressive cerebellar 
ataxia, which represents the hallmark neuropathological condition of A-T.  
 
At present, long term therapy to cure or prevent progressive symptoms of A-T are not currently 
available. While short term treatment to alleviate symptoms associated with immunodeficiency and 
deficient lung function are available to patients, the predisposition to cancer and the progressive 
neurodegeneration associated with A-T cannot be prevented with such efforts. To gain a more 
informed understanding of the A-T condition, research has focused on clinical, genetic and 
immunological aspects of the disorder; however, minimal attention has been directed towards 
identifying altered brain structure and function using imaging modalities such as magnetic resonance 
imaging (MRI).  
 
Imaging studies in A-T are limited to structural MRI imaging, where various radiological anomalies 
in patients are reported as clinical case studies. While these studies provide a detailed focus on the 
morphological and histopathological conditions of A-T, they provide limited insight into the 
mechanisms of neurodegeneration and loss of neural motor network connectivity among patients. In 
other ataxic diseases such as Friedrich’s ataxia and spinocerebellar ataxia, the use of high-resolution 
MRI and diffusion-weighted imaging (DWI) has given valuable insight into the microstructural tissue 
environment, and the loss of white matter integrity of motor networks due to abnormal 
neurodevelopmental and/or progressive neurodegenerative conditions associated with the disease. 
Such imaging approaches have not yet been extended to the study of A-T, and could provide 
important new information regarding the relationship between the ataxia-telangiectasia gene mutation 
(ATM) and loss of motor pathway integrity in A-T patients.  
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The key objective of this PhD programme was to investigate white matter integrity and grey matter 
volume changes associated with A-T using a combination of structural MRI and diffusion-weighted 
imaging, to pinpoint potential neurodegenerative biomarkers that can be targeted for therapeutic use 
among young A-T patients. Performing diffusion imaging in children with A-T presents a significant 
challenge, as spontaneous movement at resting positions form part of the A-T condition, and non-
sedated imaging procedures will contribute to excessive motion artefact and limited image quality in 
diffusion-weighted images. To effectively detect and correct for motion artefacts, a series of data pre-
processing and correction steps were introduced to the DWI processing pipeline of A-T images in 
this project. Whole brain imaging analysis, specifically voxel-based morphometry (based on 
structural MRI) was applied to interrogate and compare grey matter volume in young A-T patients 
and typically developing age-matched control participants as a preliminary starting point in 
uncovering neurodegenerative biomarkers in A-T. Tract-based spatial statistics (based on diffusion 
MRI) was employed to elucidate the white matter microstructure differences between groups, using 
the diffusion metrics fractional anisotropy (FA) and mean diffusivity (MD) as quantitative measures 
of tissue integrity. Voxel-wise analyses revealed reduced cerebellar grey matter volume and white 
matter tract degeneration in pathways projecting from the cerebellum into corticomotor regions 
among young A-T patients, indicating the need to focus on the corticomotor system in A-T.  
 
To assess white matter degeneration quantitatively in A-T corticomotor pathways, white matter fibre 
tracking and along tract statistical analyses were used to assess FA and MD differences along the 
length of cortico-ponto-cerebellar, cerebellar-thalamo-cortical, somatosensory and lateral 
corticospinal pathways between controls and patients. Significant differences in FA and MD were 
observed along the length of all patient tracts, particularly in locations pertaining to the pre- and 
postcentral gyrus, thalamus, medial and superior cerebellar peduncles and the spinal cord, suggestive 
of comprehensive motor pathway degeneration in young A-T patients.  
 
Despite numerous histopathological and anatomical studies of degeneration in A-T, the pattern of A-
T neurodegeneration over time has not been effectively captured. To this end, serial analysis using 
structural MRI, whole brain imaging methodology and automated volumetric analysis of the basal 
ganglia (caudate and putamen), thalamus and cerebellum were conducted in A-T MRI data sets 
spanning two years. Significant changes in white and grey matter integrity were absent in the A-T 
longitudinal data, however concurrent use of the A-T Neuro Examination Scale Toolkit (A-T NEST) 
clinical scores during the imaging time frame revealed loss in clinical motor functional scores for 
some participants, indicating neurodegenerative change in early stages of A-T. These findings 
highlight the need for high-resolution images to capture significant early neurodegenerative changes 
v 
 
in the A-T cohort. In addition, the inclusion of the spinal cord, a prominent area of A-T pathology, 
for study, and the incorporation of a larger, international collaborative cohort for imaging analysis 
should be considered in future A-T imaging studies.  
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CHAPTER 1 
 
Introduction  
 
Imaging in Ataxia-telangiectasia  
Ataxia-telangiectasia (A-T), an autosomal recessive neurodegenerative disorder, occurs at a rate of 3 
per million live births.1 The multi-system characteristics of this disorder are caused by genetic 
mutation of the ATM (ataxia-telangiectasia mutated) gene,2, 3 and involve progressive cerebellar 
ataxia, immunodeficiency, sinopulmonary infections, oculocutaneous telangiectasia,4, 5 and elevated 
serum alpha-fetoprotein levels.6 The ATM gene encodes for the protein kinase ATM, which plays a 
key role in the cellular response to DNA double-stranded breaks.7, 8 It is also involved in the response 
to oxidative damage, in ATM activation by oxidative stress,9 and may have more general roles in cell 
homeostasis. Upon activation, the ATM protein kinase phosphorylates a multitude of proteins that 
control various cellular processes, including different cell cycle checkpoint pathways.10 ATM gene 
mutation is linked to increased radiosensitivity in A-T patients11, 12 and in cells from these patients in 
culture.13, 14 To date, there is no long-term cure for cancer susceptibility or progressive 
neurodegeneration among A-T patients. To this end, the cause of death among most patients is 
lymphoreticular malignancy or recurrent chronic respiratory infections.4, 5 
 
The hallmark neuropathological condition of A-T is progressive cerebellar atrophy, which can extend 
to cerebral motor areas and the spinal cord with advanced age (reviewed in Sahama15). Extensive 
study of these neuropathological features have been conducted in both histopathological and post-
mortem anatomy study, however non-invasive study of A-T neuropathology using structural imaging 
modalities in living patients is limited. Indeed, conventional T1- and T2-weighted magnetic 
resonance imaging (MRI) remains the predominant imaging modality used in A-T to date (reviewed 
in Sahama15). Additional information regarding these studies can be viewed in Table 2.1 (Chapter 2) 
25 
 
and Table 2.2 (Appendices) in this thesis. Although these morphological studies have been useful 
from a radiological perspective, they provide limited information of A-T neurodegeneration and its 
associations to the loss in neural motor network integrity among patients. To capture A-T brain and 
brainstem structural integrity and identify altered structure and function of these areas accurately, 
further investigation using comprehensive imaging modalities in A-T must be conducted. In this 
regard, diffusion-weighted MRI (dMRI), particularly diffusion tensor imaging (DTI), has been 
demonstrated to provide a more accurate depiction of brain and brainstem structural integrity than 
standard MRI.16 
 
Diffusion-weighted MRI  
Diffusion-weighted magnetic resonance imaging (dMRI) measures the random motion of water 
molecules (diffusion) in the brain to infer white matter (WM) microstructure organisation of neural 
tissue. In the cellular environment of the brain, cell membranes, cytoskeletal and macromolecular 
structures hinder and restrict the movement of water molecules. In neural environments, water 
movement is hindered in the extra-axonal environment (i.e. Gaussian diffusion), whereas in the intra-
axonal environment, water movement is restricted (i.e. non-Gaussian diffusion). If diffusion is 
completely unimpeded, the mean square displacement (χ2) of particles during diffusion time Δ is 
directly related to the diffusion coefficient (D)17: 
(χ2 )= 2DΔ  
Hindered and restricted diffusion lower the mean square displacement of water in the brain and in 
turn, lower the apparent diffusion coefficient (ADC). In addition, the tight structural organisation of 
the neural axons causes greater hindered water diffusion in the direction perpendicular to the WM 
fibre bundle than in the parallel direction, causing diffusion anisotropy. It is this diffusion restriction 
and anisotropy that is used to indirectly assess the underlying microstructural organisation of neural 
tissue using dMRI in a non-invasive manner.18  
 
Diffusion image acquisition  
When acquiring diffusion-weighted magnetic resonance (MR) images of target subjects, diffusion 
sensitising gradients are added to the pulse sequence, allowing magnetic labelling of the spins of 
individual protons, and a diffusion-weighting of MR images to be achieved. The attenuation of the 
MR signal intensity (A) is observed as the diffusion component parallel to the applied diffusion 
gradients, and is given by the following equation19:  
𝐴𝐴(𝑇𝑇𝑇𝑇) =  𝑒𝑒−𝛾𝛾2𝐺𝐺2𝛿𝛿2�Δ−𝛿𝛿3�.𝐷𝐷 =  𝑒𝑒−𝑏𝑏.𝐷𝐷 
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where γ represents the gyromagnetic ratio, and G, δ and Δ are the strength, duration and separation 
of the diffusion gradient, respectively. The echo time is given by TE whereas the diffusion coefficient 
is denoted by D. A single b-value is typically used to summarise 𝛾𝛾2𝐺𝐺2𝛿𝛿2 �Δ − 𝛿𝛿
3
� . It should be noted 
that in practice, cross-terms of a combination of imaging and diffusion gradients need to be 
considered during image acquisition, thus the above equation for MR signal intensity is inaccurate. 
Exact cross-terms are numerically calculated and incorporated into a revised b-value. An echo-planar 
imaging (EPI) sequence is typically used to acquire diffusion MRI data, however other pulse 
sequences can also be employed.  
 
As previously mentioned, voxel-wise signal attenuation of the MR image is derived from diffusion 
gradients, in which the diffusion direction is the same as the diffusion sensitising gradient that is 
applied. Different contrasts can be derived for diffusion-weighted images, compared to images 
without diffusion weighting, where the contrast varies depending on the orientation of the diffusion 
gradient. In effect, the degree of diffusion restriction, corresponding anisotropy and underlying 
orientation of WM architecture can all be deduced using this property of diffusion contrasts. For 
instance, upon left-right application of the diffusion gradient, signal intensities of pathways that travel 
from left to right in the brain (i.e. commissural pathways such as the corpus callosum) are attenuated. 
Application in the anterior-posterior orientation yields signal intensities of association pathways (e.g. 
anterior limb of the internal capsule). Finally, application of the diffusion gradient in the inferior-
superior orientation attenuates signal intensities of projection pathways (e.g. posterior limb of the 
internal capsule) (Figure 1.1).  
 
Figure 1.1. The dependency of diffusion-weighted image contrasts on the direction (orientation) of 
applied diffusion encoding gradients. Axial plane images from left to right: B0 image with no 
diffusion weighting applied; left-right application of diffusion weighting (L-R) allowing signal 
attenuation of callosal pathways; anterior-posterior application of diffusion weighting (A-P) allowing 
signal attenuation of association pathways (e.g. anterior limb of the internal capsule); inferior-
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superior application of diffusion weighting (I-S) allowing signal attenuation of projection pathways 
(e.g. posterior limb of the internal capsule).  
 
A number of challenges exist with respect to acquiring diffusion images, particularly in a non-sedated 
manner, from A-T patients. The degree of motion artefact, caused by uncontrolled head movement, 
in acquired diffusion images presents a significant challenge in imaging A-T patients, due to the effect 
on data quality and corresponding accuracy of downstream statistical analysis. Specifically, head 
motion in the acquired scan leads to misalignment of brain structures between diffusion images and 
loss of signal in the image slices (volumes) of the brain where that movement artefact occurred 
(reviewed in Pannek20). In this respect, robust data pre-processing and correction methods to detect 
and remove image distortions and motion artefact in raw A-T diffusion data must be implemented 
before subsequent analysis of diffusion images. 
 
Diffusion data pre-processing 
In this project, pre-processing of raw diffusion data was conducted to detect and correct for motion 
artefacts before subsequent data analysis (Chapters 3-5) (Figure 1.2). In this protocol, raw diffusion 
data (Step 1) volumes were rejected from further downstream analysis based on within-volume 
movement (Step 2). Within the remaining image slices, signal intensity outlier voxels were detected 
and an outlier mask was created for subsequent voxel-wise processing (Step 3). Following this 
procedure, image distortions caused by susceptibility inhomogeneities were corrected and reduced 
using the diffusion data field map (Step 4). Intensity inhomogeneities within the image were removed 
(Step 5) and distortions caused by head movement were corrected within images (Step 6). Finally, 
the slice-wise outlier mask created in Step 3 was used as input to detect signal intensity outlier voxels 
(i.e. caused by cardiovascular pulsation, bulk head motion, etc.), which were replaced within images 
(Step 7) to acquire corrected diffusion data (Step 8) for subsequent downstream statistical analysis 
(Figure 1.2). For a detailed review of this pre-processing protocol, the reader is referred to the journal 
article by Pannek et al. (2012).20  
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Figure 1.2. Raw diffusion data pre-processing pipeline. Raw diffusion data (Sagittal image, Step 1) 
was used as input for this protocol. Within-volume movement was detected in raw diffusion data 
volumes, and volumes were rejected from further downstream analysis (Step 2). Within the remaining 
image slices, signal intensity outlier voxels were detected and an outlier mask was created for 
subsequent voxel-wise processing (Step 3). Image distortions caused by susceptibility 
inhomogeneities were corrected and reduced using the diffusion data field map (Step 4). Intensity 
inhomogeneities within the image were removed (Step 5) before distortions caused by head 
movement were corrected within images (Step 6). Slice-wise outlier masks (output from Step 3) were 
used as input to detect and replace signal intensity outlier voxels (i.e. caused by cardiovascular 
pulsation, bulk head motion, etc.) in images (Step 7) to acquire corrected diffusion data (Step 8) in 
the form of fractional anisotropy (FA; green) and mean diffusivity (MD; orange) maps (pictured here 
in the sagittal plane).  
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Diffusion tensor imaging 
To comprehensively probe corticomotor-cerebellar integrity in ataxic conditions,21-28 diffusion tensor 
imaging (DTI),29 a model of dMRI, is used. The diffusion tensor describes the molecular displacement 
(D) of water in the brain in three dimensions (x, y and z) and is comprised of a 3×3 matrix as shown: 
D = �
𝐷𝐷𝑥𝑥𝑥𝑥 𝐷𝐷𝑥𝑥𝑥𝑥 𝐷𝐷𝑥𝑥𝑥𝑥
𝐷𝐷𝑥𝑥𝑥𝑥 𝐷𝐷𝑥𝑥𝑥𝑥 𝐷𝐷𝑥𝑥𝑥𝑥
𝐷𝐷𝑥𝑥𝑥𝑥 𝐷𝐷𝑥𝑥𝑥𝑥 𝐷𝐷𝑥𝑥𝑥𝑥
� 
These six independent elements of the above diffusion tensor matrix (Dxx, Dyy, Dzz, Dxy, Dxz and Dyz) 
are calculated by acquiring six diffusion weighted images at the minimum, with application of 
diffusion gradients in noncollinear directions. Despite this convention, acquisitions that utilise a 
minimum of 30 unique orientations that are distributed using the electrostatic approach30 have been 
required for robust tensor orientation estimation.31 Recent acquisition methods have also incorporated 
the use of multiple diffusion weightings or ‘multi-shell’ methods to capture the main tissue types of 
the brain (WM, grey matter (GM) and cerebrospinal fluid (CSF)) more effectively. This method aims 
to overcome the limitations of the single constant diffusion weighting acquisition or ‘single shell’ 
method, to elucidate information in tissue types that cannot be distinguished using the standard single-
shell approach.32 The diffusion tensor is visualised as an ellipsoid, where the axes of the ellipsoid 
�
𝜀𝜀1
→,
𝜀𝜀2
→ ,
𝜀𝜀3
→� are given by the eigenvectors of the diffusion tensor and the length is given by the 
eigenvalues (𝜆𝜆1, 𝜆𝜆2, 𝜆𝜆3) of the diffusion tensor (Figure 1.3).  
 
Figure 1.3. The ellipsoid visualisation of the diffusion tensor. In isotropic environments, the 
eigenvector length of the diffusion tensor is equal and the tensor is represented by a sphere (Left). 
In anisotropic environments, the principal eigenvector 
𝜀𝜀1
→ length is greater than the lengths of the 
other eigenvectors �
𝜀𝜀2
→ ,
𝜀𝜀3
→ � and the corresponding tensor shape is a ‘cigar’ (Right).  
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Based on the eigenvalues of the diffusion tensor, a number of quantitative diffusion metrics can 
be calculated in DTI. The diffusion metrics used in this thesis are fractional anisotropy (FA) and 
mean diffusivity (MD), respectively. FA, a unit-less scalar value between 0 (isotropic water 
diffusion) and 1 (anisotropic water diffusion), measures the organisation of specific WM axonal 
pathways in the brain.33 FA is given by the following equation, where λ is the average of the three 
diffusion tensor eigenvalues:  
FA = �
3
2
 . �(𝜆𝜆1− 𝜆𝜆)2+ (𝜆𝜆2− 𝜆𝜆)2+ (𝜆𝜆3− 𝜆𝜆)2 
𝜆𝜆1
2+ 𝜆𝜆22+ 𝜆𝜆32  
FA is dependent on the uniform direction of water movement (degree of anisotropy) in WM 
pathways.33 In areas of unrestricted water diffusion in the brain, low FA values are recorded, 
whereas high FA values are observed in areas containing highly organised WM microstructure 
(Figure 1.4). Colour coded FA maps are used for visualisation as part of the dMRI image 
processing pipeline, and incorporate the directional information of the principal eigenvector 
𝜀𝜀1
→ .34 
Indeed, in single fibre voxels (pixels of the MRI image), the principal eigenvector is believed to 
coincide with the orientation of WM architecture, allowing easier identification and improved 
analysis of major WM tracts.35  
 
MD or the Apparent Diffusion Coefficient (ADC) provides a measure of the mean motion of 
water in all directions in the given space36, 37: 
MD = 1
3
(𝜆𝜆1 + 𝜆𝜆2 + 𝜆𝜆3) 
It is equivalent to 1 3�  of the Trace of the diffusion tensor. MD values share an inverse relationship 
to FA values. In areas of high WM microstructure organisation, low MD values are observed 
whereas relatively high levels of MD are recorded in areas where fewer fibres restrict water 
movement (reviewed in Mori38) (Figure 1.4). This inverse relationship is used to characterise WM 
degeneration. Specifically, a decrease in FA and an increase in MD, where lower FA is indicative 
of reduced uniform diffusion direction and by extension, WM fibre alignment,33 indicates WM 
degeneration.  
 
Other diffusion metrics that are calculated in DTI are axial (λ||) and radial (λ⊥) diffusivity, 
respectively. Axial diffusivity is equal to the primary eigenvector magnitude (parallel diffusion) 
whereas radial diffusivity represents the average of the two tertiary eigenvectors (diffusion 
direction that is perpendicular to the primary vector). Typically, in areas of unrestricted water 
diffusion, an increase in radial diffusivity and either increases, decreases or relatively no change 
in axial diffusivity are recorded.39 These measures were not utilised for this project. 
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Figure 1.4. Fractional anisotropy (FA) and mean diffusivity (MD). FA and MD changes 
respective of white matter (WM) fibre organisation and distribution. 
 
Image processing methodology 
Following pre-processing of diffusion data, the following analysis pipelines were used in this project 
to statistically analyse imaging data. The image processing pipelines are presented in order of the 
type of input data needed for the analysis. In this project, T1-weighted structural images and pre-
processed diffusion data (FA and MD images) were used as input images for analysis, respectively.  
 
Structural T1-weighted images 
T1- (and T2)-weighted structural images are image contrasts acquired by using pulse sequences in 
MR image acquisition. T1-weighted images are used to differentiate anatomical structures, where 
tissue with high fat content (i.e. WM) appear bright and water-filled compartments (i.e. CSF) appear 
dark. Conversely, in T2-weighted images, compartments filled with water appear light, whereas tissue 
with high fat content appear dark. In this project, both T1- and T2-weighted images, that provide 
high-resolution structural information of brain anatomy and pathology (cortical morphology), were 
used to characterise degeneration in A-T patients (Figure 1.5).  
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Figure 1.5. Sagittal T1-weighted (Left) and axial T2-weighted (Middle and Right) structural images 
of an ataxia-telangiectasia patient. T2-weighted images picture the lateral and fourth ventricles of the 
brain respectively.  
 
As previously mentioned, the main challenge of analysing brain images in A-T is the prevalence of 
motion artefacts in the image. In contrast to established pre-processing protocols for diffusion data 
(see ‘Diffusion data pre-processing’ section in this Chapter), based on detecting and correcting for 
motion artefact in multiple diffusion image volumes of the brain, there is no method by which motion 
artefact can be removed from T1 structural images, to reduce the impact of data quality on 
downstream processing and statistical analysis. Despite this limitation, careful visual examination of 
images derived from processing pipelines that use T1 images as input, and manual editing of 
structural errors where they were detected in such images ensured the accuracy of analyses in this 
project.  
 
Voxel Based Morphometry 
A number of elegant methods, whereby structural changes are measured in the whole brain of subjects 
in a voxel-wise manner, have been developed. One such method is Voxel Based Morphometry 
(VBM), where the GM volumetric changes between two conditions (i.e. control and diseased cohorts) 
are measured using T1-weighted structural images (Step 1, Figure 1.6).40, 41 In the VBM analysis used 
in this project, T1-weighted images were skull-stripped (the brain is extracted from the structural 
image), GM segmented (WM and CSF spaces of the image were removed) (Step 2), and resulting 
images were registered to a standard space (Step 3) before images were averaged and flipped along 
the x-axis to create a GM template with specific left-right symmetry (Step 4). After non-linear 
registration of GM segmented images to this template, voxels within the resulting image were 
smoothed (according to VBM recommendations)40-42, to ameliorate residual misalignments of images 
(Step 5), before voxel-wise statistical analyses were conducted (Step 6). Significant changes between 
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groups were marked on the GM template in the corresponding brain area (Figure 1.6, shown in 
yellow). For this project, an optimised VBM protocol using FMRIB’s Software Library (FSL) tools 
was used (Chapter 3).  
 
Figure 1.6. Voxel Based Morphometry (VBM) processing pipeline. This processing pipeline uses 
T1-weighted structural images (Sagittal image, Step 1) from control and patient groups. T1 images 
underwent brain extraction and grey matter (GM) segmentation (Step 2), before registration to 
standard space (Montreal Neurological Institute (MNI) 152 standard space was used, Step 3). A GM 
template was created with specific left-right symmetry (Step 4), followed by non-linear registration 
of GM segmented images to this template (Step 5). Voxels within the resulting image were smoothed, 
to ameliorate residual misalignments of images (Step 5), before voxel-wise statistical analyses were 
conducted (Step 6). Significant GM volumetric changes between control and patient groups are 
indicated on the GM template in the corresponding brain area (Yellow, Step 6). 
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The main advantages of a VBM-style analysis is that it is fully automated and only requires structural 
T1 data for analysis. One significant challenge however, is the inherent alignment issues of the atlas 
space (i.e. Montreal Neurological Institute (MNI) 152 standard space for VBM) that occur during 
processing for statistical analysis. Specifically, it is not possible to say for certain that any given voxel 
in the space in which voxel-wise statistics will be carried out, accurately represents corresponding 
data from all subjects in a given anatomical region.43, 44 The second limitation in VBM-style analyses, 
is the arbitrary choice of smoothing designated for the analysis. Final results have been found to 
depend very strongly on the choice of smoothing.45 In addition, smoothing can also increase the 
partial voluming problem, where it is difficult to observe whether estimated structural changes are 
due to genuine changes in volume and structure, rather than by changes in the amount of tissue types 
(reviewed in Smith44). To address these limitations in the current project, visual cross-checking of 
alignment issues46 and manual editing of resultant volumes, followed by careful post-statistics 
analysis, was conducted at all stages of the VBM processing pipeline to ensure the accuracy of the 
automated VBM alignment process. 
 
Cortical and Subcortical Segmentation 
As whole brain analysis methods are automated, selection or segmentation of specific cortical brain 
regions is relatively easy. One prominent model-based segmentation/registration tool in VBM to 
conduct GM segmentation of structural images is FMRIB’s Integrated Registration and Segmentation 
Tool (FIRST),47 which can also be used as a standalone tool to segment individual areas of interest 
in the brain (Chapter 5). Within the FIRST protocol used in this project (Figure 1.7), T1-weighted 
structural images were cropped at the neck and skull-stripped (Step 2) before applying the FIRST 
script to segment all sub-cortical structures of the brain (Step 3). The output of this script were mesh 
and volumetric structural (colour coded template masks, Figure 1.7) outputs of the selected brain 
regions (Step 4, Figure 1.7). It should be noted however, that certain brain areas (i.e. cerebellum) are 
particularly sensitive to image resolution48 and that the quality of T1 structural images determines the 
effectiveness by which target brain areas are segmented using FIRST. In this project, motion artefact 
and image distortions in T1 images presented a challenge in the automated segmentation of brain 
structures for analysis. Indeed, in instances where the cerebellum was selected, careful manual 
segmentation of structures was required to ensure the accuracy of downstream volumetric 
measurements and subsequent statistical analysis of the cerebellum (Chapter 5).  
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Figure 1.7. FMRIB’s Integrated Registration and Segmentation Tool (FIRST) processing pipeline. 
Within this protocol, T1-weighted structural images (Sagittal image, Step 1) were cropped at the neck 
and skull-stripped (Step 2) before the FIRST script was applied to segment all sub-cortical structures 
of the brain (Step 3), and provide mesh and volumetric structural outputs of the selected brain regions 
(Step 4). Volumetric structural outputs of the caudate (blue), putamen (pink) and thalamus (green) 
are represented on skull-stripped T1-weighted images in the axial (left) and coronal (right) planes, 
respectively (Step 4).  
  
Diffusion images 
Tract-Based Spatial Statistics 
Whole brain voxel-wise analysis of diffusivity measures (FA and MD) is conducted using Tract-
Based Spatial Statistics (TBSS, Figure 1.8).42, 44 TBSS is a sensitive analysis used in this project 
where FA and MD images from multiple subjects in control and patient cohorts were aligned via 
registration (non-linear) to a standard space (Step 2), and subsequently projected onto an alignment-
invariant tract representation (or ‘mean FA skeleton’) (Steps 3-4). Following this image projection, 
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voxel-wise statistical comparisons of WM microstructure change were made between controls and 
A-T patients (Step 5). Significant WM changes between groups were marked on the FA skeleton in 
the corresponding brain area (Figure 1.8, shown in red).  
 
Figure 1.8. Tract-Based Spatial Statistics (TBSS) processing pipeline. In the TBSS processing 
pipeline, fractional anisotropy (FA) and mean diffusivity (MD) images from multiple subjects in 
control and patient cohorts were non-linearly registered for image alignment to a standard space 
(FMRIB58 FA space, Step 2), and subsequently projected onto an alignment-invariant tract 
representation (or ‘mean FA skeleton’) (Steps 3-4). Voxel-wise statistical comparisons of white 
matter (WM) microstructure change were made between controls and patient cohorts, where 
significant WM changes between groups where highlighted (red) in the FA skeleton by brain region.  
 
Like all VBM-style analyses, TBSS is fully automated and only requires pre-processed diffusion data 
for analysis. It is limited by the inherent alignment issues of the atlas space (FMRIB58 FA space) 
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during processing, specifically, it is not guaranteed that the same region of the same WM tract from 
each analysed subject has been accurately captured per voxel in the space in which voxel-wise 
statistics will be carried out.43, 44 In addition, limited information about the specific WM tracts that 
traverse the area of affectation is revealed using TBSS, enforcing the need for specialised and 
comprehensive analysis of specific WM tracts of interest in areas of structural change (i.e. 
tractography). The aforementioned quality of TBSS image registration also confounds the anatomical 
specificity of specific tracts within this analysis.49 Similar to VBM analysis, the smoothing choice 
made during TBSS processing has a strong influence on the final results,45 and can increase partial 
voluming problems.44 To resolve these issues, visual cross-checking of alignment issues46 followed 
by careful post-statistics analysis was conducted at all stages of the TBSS processing pipeline to 
ensure the accuracy of subsequent results. 
 
Tractography 
In addition to providing information about the microstructural organisation of the brain, DTI, 
specifically the directional information within the diffusion signal (direction of water diffusion), can 
be used to track WM pathways (Figure 1.9), in a process known as tractography. To track WM tracts 
from voxel to voxel, early tractography methods used the direction of the principal eigenvector 
𝜀𝜀1
→ of 
the diffusion tensor.50-52  
 
Figure 1.9. Tractography of the corticospinal tracts in the sagittal (left) and coronal (right) views. 
Bilateral tracts were extracted using probabilistic tractography based on constrained spherical 
deconvolution, in a typically developing subject.  
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Limitations of DTI and Tractography 
In diffusion images, almost 90% of WM voxels comprise of complex WM architecture and crossing 
fibres.53 DTI is limited in resolving this complex architecture and crossing fibre pattern.54 Unintuitive 
DTI measures are derived from voxels containing multiple crossing fibres, particularly in 
neurodegenerative diseases where increased FA measures can be observed in degenerative regions.55 
In cases of Wallerian degeneration, changes in diffusion anisotropy may not be observed in 
degenerated pathways crossing other tracts.56 In addition, false-positive (i.e. presence of non-existent 
tracts) and false-negative (i.e. inability to delineate existing tracts) errors may accumulate in 
tractography-derived WM pathways when crossing fibres are analysed using diffusion tensor 
tractography. This is due to a lack of correspondence in orientation between the principal eigenvector 
of the diffusion tensor and WM architecture.  
 
In the cases outlined above, changes in the diffusion tensor can be interrogated by using more than 
one DTI metric (i.e. both FA and MD as in this project) to observe neuropathology in 
neurodegenerative disease states (reviewed in Alexander57). To resolve multiple crossing fibres 
within voxels, a number of higher order models of the diffusion signal can be used. For this project, 
constrained spherical deconvolution (CSD)58 implemented in the MRtrix software package59 was 
used to estimate fibre orientations and improve the resolution of multiple crossing fibre tracts in a 
given voxel.60, 61 To estimate the fibre orientation distribution (FOD) by spherical deconvolution,62 
the response function (diffusion signal of single fibre voxels) is measured before applying it as a 
convolution kernel with the diffusion signal in all voxels. In effect, FOD reconstructions display the 
orientations of underlying WM tracts as multiple ‘lobes’ (Figure 1.10). A more robust FOD 
reconstruction is achieved with an additional non-negativity constraint58 that ensures positive volume 
fractions of contributing fibre populations. The information contained within the MRtrix-derived 
FOD can be used in tractography to drive WM fibre delineation, with greater accuracy than diffusion 
tensor based tractography methods without a higher order model approach,54 and is the method 
implemented in this project. 
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Figure 1.10. Fibre orientation distribution (FOD) estimated using constrained spherical 
deconvolution (CSD). In regions of crossing fibres, multiple ‘lobes’ as depicted (right) are used to 
represent the underlying white matter orientations.  
 
MRTrix3 Tractography 
In this project, a newly released demonstrative version of the MRtrix program, MRTrix3, was 
implemented for probabilistic tractography analysis. In comparison to MRtrix, MRTrix3 offers two 
novel features that assist in the extraction of tracts that are anatomically constrained to the brain space 
of individual subjects, and that improve quantitative whole brain streamline reconstruction for 
subsequent tract extraction. The first feature is called anatomically constrained tractography (ACT)63 
and is a framework used to confine tracts in the brain to the brain space of individual subject images. 
Tractography operates by following the local water diffusion direction from voxel to voxel from a 
start (seed) point, until the tractography streamline terminates according to pre-defined criteria. One 
important criterion for termination is when streamlines attempt to leave the brain region (brain mask). 
The ACT framework ensures that streamlines are anatomically constrained to the brain mask.  
 
In this project, structural T1-images registered to the diffusion image (FA image) were used as input 
for the MRTrix3 processing pipeline, specifically for the ACT protocol (Step 1, Figure 1.11). T1 
images were skull-stripped and segmented using the FSL Brain Extraction Tool (BET) and 
segmentation tools (FIRST and FMRIB’s Automated Segmentation Tool (FAST)) respectively, to 
remove the encasing skull in the image and segment the brain into five tissue types (i.e. cortical grey 
matter, sub-cortical grey matter, white matter, cerebrospinal fluid and pathological tissue). The 
resulting image was a ‘five tissue types’ mask (Step 2) which was subsequently used to produce 
whole brain tractography maps (tractograms) (Step 3).  
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Figure 1.11. MRTrix3 processing pipeline. T1-weighted structural images registered to diffusion 
image space (Fractional Anisotropy (FA) image, Step 1) were skull-stripped and segmented using the 
FSL Brain Extraction Tool (BET) and segmentation tools (FMRIB’s Integrated Registration and 
Segmentation Tool (FIRST) and FMRIB’s Automated Segmentation Tool (FAST)) respectively, to 
create ‘five tissue types’ masks as part of the Anatomically Constrained Tractography (ACT) 
framework (Representative ‘five tissue types’ mask presented in the sagittal, coronal and axial planes 
respectively, Step 2). The resulting mask was used to produce whole brain tractography maps 
(tractograms) (Representative whole brain tract images are overlaid on the FA map in the sagittal, 
coronal and axial planes respectively, Step 3). The Spherical-deconvolution Informed Filtering of 
Tractograms (SIFT) framework was utilised on whole brain tractograms (Representative SIFTed 
whole brain tract images are overlaid on the FA map in the sagittal, coronal and axial planes 
respectively, Step 4) before subsequent extraction of white matter (WM) tracts of interest using region 
of interest (ROI) selection of tracts from whole brain tracts (Steps 5-6). Finally, quantitative methods 
to extract fractional anisotropy (FA) and mean diffusivity (MD) metrics and identify structural 
differences along fibre bundles were conducted using resultant tracts. 
 
Following generation of whole brain tractograms in the MRTrix3 probabilistic tractography pipeline, 
tractograms were processed using the second new feature of the new MRtrix software. This feature 
is termed Spherical-deconvolution Informed Filtering of Tractograms (SIFT) (Step 4, Figure 1.11).64 
SIFT ensures that within the produced tractography reconstruction, the number of connecting 
streamlines between two brain regions match spherical deconvolution estimated WM fibre densities 
(cross-sectional areas) between these regions. In effect, SIFT ensures that the derived tracts are 
captured as they would appear in true biological constraints within the subject.  
 
Following SIFT processing of whole brain tractograms, ROIs were manually selected in directionally 
encoded colour (dec) FA maps, derived from pre-processing raw diffusion data. The decFA colour 
scheme displays the fibre orientation in the image; specifically red represents left-right orientation, 
blue represents inferior-superior orientation and green represents anterior-posterior orientation of 
fibres. ROI placement and subsequent tract extraction relies on anatomical expertise of brain 
structures within the decFA image (Figure 1.12). In this project, ROIs were selected and subsequently 
used to extract tracts of interest from SIFTed whole brain tractograms (Steps 5-6, Figure 1.11).  
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Figure 1.12. First row: Tractography of white matter (WM) corticospinal (left) and corticomotor-
cerebellar (middle and right) tracts from a typically developing control subject in the sagittal T1-
weighted image. Coronal images (middle and right) show decussation of corticomotor-cerebellar 
tracts. Yellow lines indicate corresponding region of interest (ROI) placement. Second row: ROI 
selection of the postcentral gyrus (left), medial cerebellar peduncle (MCP; middle) and superior 
cerebellar peduncle (SCP; right) marked on a directionally encoded colour fractional anisotropy 
(decFA) image in the axial (left) and coronal (middle and right) planes, respectively. The decFA 
colour scheme is represented as follows: red (left-right fibre orientation), blue (inferior-superior fibre 
orientation) and green (anterior-posterior fibre orientation). 
 
In contrast to automated voxel-wise image processing methods, the use of ROIs to select WM tracts 
of interest from whole brain tractography can be time consuming, especially when many structures 
require manual selection and/or a large number of participants are involved in the analysis. The ROI 
approach is largely operator-dependent, thus to ensure adequate intra- and inter-rater reproducibility, 
ROIs should be drawn consistently each time by the same operator and different operators. Despite 
these challenges, ROI analysis is recommended in cases where changes in specific brain regions need 
to be observed. 
 
Quantitative Tract Measurements 
Along Tract Analysis  
Following the extraction of WM tracts of interest in this project, a number of methods to derive 
quantitative tract measurements from the tracts were used (Step 7, Figure 1.11). The first method is 
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called ‘Along Tract Analysis’, which was used to measure diffusion tensor metrics (FA and MD) 
along the length of selected tracts (Figure 1.13). In this protocol, motor pathways were first defined 
by ‘start’ and ‘end’ ROIs (placed in the cerebral cortex and culminating at the brainstem level, 
respectively) (Step 1) and cropped at ‘end’ ROIs to ensure similar tract length of all tracts within the 
circuit (Step 2). Spurious tracts were removed by rejecting the longest tracts in motor circuits (Step 
3). Diffusion metrics (FA and MD) were subsequently sampled in the remaining selection of tracts 
by automated segmentation of individual tracts into a pre-determined number of locations (bins) of 
equal streamline point count, to ensure minimal data variance in metrics along the tract (Steps 4-5, 
Figure 1.13). This approach ensured anatomically coincident bins to be sampled along each tract of 
interest for each individual subject (Figure 1.14). The advantage of the along tract protocol is its 
ability to capture the immense amount of anatomical variability in WM microstructure along the 
length of selected tracts.65 An alternative to the along tract method is the more commonly used ‘tract-
averaged’ approach, whereby FA and MD values are derived along the length of the tract selection 
and averaged to provide one single point spread estimate of FA or MD per tract. Using this second 
method, potential variances in WM microstructure are lost, therefore this project takes advantage of 
the along tract protocol to effectively capture WM microstructural variability in the heterogeneous 
A-T cohort under study.  
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Figure 1.13. Along Tract Analysis pipeline. Motor pathways were first defined by ‘start’ and ‘end’ 
regions of interest (ROIs) (placed in the cerebral cortex and culminating at the brainstem level 
respectively, Step 1). In this figure, representative corticospinal tracts overlaid on a sagittal fractional 
anisotropy (FA) image are presented in Steps 1 and 4, where fibre orientation of tracts in the left-right 
direction are highlighted in red, in the inferior-superior direction are highlighted in blue and in the 
anterior-posterior direction are highlighted in green, respectively. Tracts were cropped at ‘end’ ROIs 
to ensure similar tract length of all tracts within the circuit (Step 2). Spurious tracts were removed by 
rejecting the longest tracts in motor circuits (Step 3). Diffusion metrics (FA and mean diffusivity 
(MD)) were subsequently sampled in the remaining selection of tracts by automated segmentation of 
individual tracts into a pre-determined number of locations (Bins, represented by yellow markings on 
corticospinal tracts, Step 4) of equal streamline point count, to ensure minimal data variance in 
metrics along the tract (Steps 4-5). 
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Figure 1.14. Representative graphs from the Along Tract Analysis pipeline. A) Smooth estimates of 
the average fractional anisotropy (FA) of a representative control (blue) and patient (red) corticospinal 
tract in the left cerebral hemisphere are plotted versus position from tract origin (cerebral motor cortex 
(0%) – brainstem level spinal cord (100%)), ± pointwise 99% confidence range (blue: control, red: 
patient)). B) Smooth estimates of the average mean diffusivity (MD) of a representative control (blue) 
and patient (red) corticospinal tract in the left cerebral hemisphere are plotted versus position from 
tract origin (cerebral motor cortex (0%) – brainstem level spinal cord (100%)), ± pointwise 99% 
confidence range (blue: control, red: patient)). Tract position at 0-5% represents precentral and 
postcentral gyrus layers, at 47-58% represents thalamic layers and at 95-100% represents the spinal 
cord at the level of the brainstem in corticospinal tracts, respectively.  
 
Streamline Number, Tract Volume and Apparent Fibre Density 
Additional measurements taken from selected tracts in this project were streamline number, tract 
volume and apparent fibre density (AFD). Streamline number and tract volume, derived directly from 
the tract using robust FSL statistical tools, can be used to identify structural differences along fibre 
bundles. Similarly, AFD, which is derived from the FOD lobe parallel to the streamline direction, 
allows the structural differences along single fibre bundles and the corresponding connectivity 
between two anatomic regions between a tract to be identified.66 Specifically, it combines information 
from intra-voxel fibre density and tract cross-sectional area (anatomic region) to identify tracts with 
reduced fibre density, an analysis component that is useful when studying WM microstructure in 
neurodegenerative diseases.  
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Thesis Aims and Objectives 
Performing diffusion imaging in children with ataxias presents a significant challenge. A-T patients 
particularly, display spontaneous movement at resting positions and imaging procedures where non-
sedated scanning is conducted will contribute to excessive motion artefact in diffusion-weighted 
images. This presents a considerable limitation to data quality which, through a series of data pre-
processing and correction steps, have been largely addressed in this thesis (Chapters 3-5). Second, 
young A-T patients display competing effects of white and grey matter maturation and degeneration 
in structural integrity studies, therefore data from this project should be viewed in consideration of 
this competing effect. Finally, heterogeneous neurodegeneration and clinical observations in the A-T 
cohort can and should be expected. Analysis and interpretation of A-T diffusion imaging data should 
ideally be conducted on a case-by-case basis, with strong linkage to individual clinical observations 
where possible. Despite these challenges, diffusion imaging studies are urgently needed to fully 
elucidate the relationship between ATM gene mutation and loss in integrity of motor circuitry in A-
T patients.  
 
In this context, this PhD project aims to: 
 
1. Assess whole brain cortex and subcortical WM and GM morphological changes between A-
T patients and typically developing participants  
 
2. Investigate if A-T neuropathy is localised to the cerebellum or extends to the entire motor 
cortex in select WM pathways in A-T  
 
3. Investigate if A-T neuropathy is localised to the cerebellum or extends to the entire motor 
cortex in serial study of patients 
 
Thesis Format 
The above listed aims are presented in three of the six chapters of this thesis. This thesis consists 
primarily of publications, where chapters 2, 3, 4 and 5 are manuscripts that have either been published 
or have been submitted for peer review to an international journal. Each manuscript in general, 
consists of an introduction, methods, results, discussion and if applicable, a conclusions section. Each 
manuscript was written to be a standalone publication, therefore there may be repetition of 
information, particularly of the methodology in this thesis. The specifics of each chapter following 
the current chapter are detailed below. 
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Chapter 2 contains a literature review published in the journal Cerebellum in 2014. This chapter 
reviews A-T anatomical and histopathological findings, the involvement of MR modalities and 
identification of disease conditions using these modalities in A-T, and future imaging work that is 
needed in the area.  
 
Chapter 3 addresses the first aim of this project and contains a research article published in the journal 
Movement Disorders in 2014. This paper implements whole brain WM and GM imaging in A-T 
patients for the first time, to analyse GM volume alterations and WM microstructure differences 
between healthy controls and patients, to understand the differences in structural integrity underlying 
A-T.  
 
Chapter 4 addresses the second aim of this project and contains a research article published in the 
journal NeuroImage Clinical in 2015. This paper details the computational analysis of diffusion 
tensor metrics (FA and MD) along the length of somatosensory, corticospinal and select corticomotor 
cerebellar tracts in control and patient data. The paper highlights the effectiveness of along tract 
methodology in studying brain WM connectivity, specifically by calculating FA and MD at consistent 
intervals along tract length, thereby providing a comprehensive view of the anatomical variation in 
WM integrity along the assessed neural pathways. 
 
Chapter 5 addresses the third aim of this project and contains a research article submitted for peer 
review to the journal Paediatric Neurology in 2015. This report details the results of longitudinal 
whole brain WM and GM analysis, used to track neurodegenerative progression in patients over the 
first, second and third years of MRI scanning in this project. Additional volumetric analysis of key 
corticomotor areas of the brain are also included to provide a complete picture of the progress of 
neurodegeneration over two years in A-T patients. 
 
Finally, Chapter 6 contains a summary of findings detailed in Chapters 3-5 and presents limitations 
specific to each study. General limitations of the project are also discussed and future implications 
and avenues of research for this project are presented. 
 
48 
 
 
 
 
 
 
 
CHAPTER 2 
 
Radiological Imaging in Ataxia-
telangiectasia: a Review 
 
The second chapter consists of a systematic literature review published in the journal Cerebellum in 
2014. The review presents a broad introduction to the multi-faceted nature of ataxia-telangiectasia 
(A-T) symptomology followed by a concise review of the cerebral, cerebellar and spinal cord 
histopathology of the disease. The biochemical and physiological causes of A-T neurodegeneration 
and relevant short-term therapies are presented. The prevalence of predominately radiological 
imaging in A-T is discussed and contrasted to the lack of diffusion imaging application in the A-T 
imaging arena. The paper concludes with the potential benefits of applying diffusion imaging to A-
T, which are improvements to the investigation of the microstructural tissue environment, and the 
ability to uncover the mechanics behind loss of motor network integrity in A-T non-invasively. It 
should be noted that since the publication of this review article, a number of studies utilising structural 
brain imaging modalities in young A-T patients have been published and are recorded in Table 2.2 in 
the Appendices of this thesis.  
 
As the first author of this paper, I drafted and primarily edited the article. My co-author Stephen Rose 
assisted in the drafting and critical editing of the manuscript. My co-authors Kate Sinclair, Kerstin 
Pannek and Martin Lavin contributed to the conception and design of this project and to the critique 
of this manuscript.  
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Abstract  
The human genetic disorder ataxia-telangiectasia (A-T) is characterised by neurodegeneration, 
immunodeficiency, radiosensitivity, cell cycle checkpoint defects, genomic instability and cancer 
predisposition. Progressive cerebellar ataxia represents the most debilitating aspect of this disorder. 
At present, there is no therapy available to cure or prevent the progressive symptoms of A-T. While 
it is possible to alleviate some of the symptoms associated with immunodeficiency and deficient lung 
function, neither the predisposition to cancer nor the progressive neurodegeneration can be prevented. 
Significant effort has focused on improving our understanding of various clinical, genetic and 
immunological aspects of A-T; however, little attention has been directed towards identifying altered 
brain structure and function using MRI. To date, most imaging studies have reported radiological 
anomalies in A-T. This review outlines the clinical and biological features of A-T along with known 
radiological imaging anomalies. In addition, we briefly discuss the advent of high-resolution MRI in 
conjunction with diffusion-weighted imaging, which enables improved investigation of the 
microstructural tissue environment, giving insight into the loss in integrity of motor networks due to 
abnormal neurodevelopmental or progressive neurodegenerative processes. Such imaging approaches 
have yet to be applied in the study of A-T and could provide important new information regarding 
the relationship between mutation of the ataxia-telangiectasia mutated (ATM) gene and the integrity 
of motor circuitry. 
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A-T and Genetic Origins  
Ataxia-telangiectasia (A-T, Louis–Bar syndrome) is an autosomal recessive neurodegenerative 
disorder that occurs in 1 per 88,000 live births in the USA.67 In the UK, an estimated fourfold lower 
incidence of approximately three per million live births has been reported.1 The disease was first 
characterised in 194168 and localised to chromosome 11 q22-q23 in 1988.2 Multi-system 
characteristics associated with A-T were subsequently shown to be a result of mutation in a single 
gene, ATM (ataxia-telangiectasia mutated)3 and include progressive cerebellar ataxia, 
immunodeficiency, sinopulmonary infections, oculocutaneous telangiectasia4, 5 and elevated serum 
alpha-fetoprotein levels.6 The ATM gene encodes for the protein kinase ATM, a key player in the 
cellular response to double-stranded DNA damage69 and multiple cell cycle checkpoint pathways.10 
As such, ATM gene mutation is associated with increased radiosensitivity in A-T patients.13, 70-81 The 
causes of death in most patients are lymphoreticular malignancy or recurrent chronic respiratory 
infections.4, 5 
 
A-T Neuropathology 
Since the localisation of the ATM gene to chromosome 11, over 500 different ATM mutations have 
been identified that give rise to unique A-T case symptoms;82-84 some of which are characteristic from 
family to family.85-87 This genetic variation extends to the neurological symptoms of A-T, which 
differ on a case-by-case basis and can be grouped by anatomic region. Known neuropathology based 
on post-mortem studies in A-T is summarised below. 
 
Cerebrum 
Anatomical studies in A-T have reported widely distributed cerebral tissue vascular changes. The 
presence of numerous Lewy bodies and moderate nerve cell loss in the substantia nigra represent part 
of these changes.87-91 Haemosiderin scarring in frontal lobe white matter (WM), the parietal area, 
including the parietal operculum, in the temporal lobe, in the subcortical area of both occipital lobes 
and capsula externa has been reported.91, 92 Smaller scarring has been observed in the WM of the 
precentral and postcentral gyrus92 as well as moderate cortical gliosis of the central and parietal gyri.88 
Lesions within the thalamus have been reported.88, 90 Basal ganglia pathology in A-T has also been 
described, particularly glial scarring and demyelination in the frontal plane sections of both basal 
ganglia hemispheres.92 
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Cerebellum 
Cerebellar pathology in A-T includes cerebellar atrophy of the frontal and posterior vermis and 
atrophy of both cerebellar hemispheres, particularly in the middle and superior cerebellar peduncles 
(brachia pontis and conjunctiva, respectively).87, 88, 90-98 On a microscopic scale, the loss of Purkinje 
cells and loss or reduction of granular cell layers, especially in the anterior cerebellar vermis, is a 
hallmark feature in A-T.11, 88, 89, 91-94, 97-100 Abnormal nuclear and dendritic arborisations in Purkinje 
neurons have also been reported.88, 94 A number of generalised findings relating to the loss of occipital 
cortex pyramidal cells, smaller than average dentate nucleus, larger than average inferior olivary 
nucleus venules, where the inferior olivary nuclei showed nerve cell loss and reduced myelinated 
fibres in the nervus hypoglossas and enlarged venules in the cerebellar meninges have been 
described.87-89, 97, 98 
 
Brainstem 
Brainstem abnormalities in A-T are dependent on individual patients and age. In some studies, no 
brainstem abnormalities were seen.95, 98 In other cases, glial nodules in pyramidal tracts and the medial 
lemnisci and gliosed gracile nuclei were observed.94 Sectional demyelination of the pons and 
midbrain in the brachia conjunctiva and pontis has also been reported.92 Other more comprehensive 
case studies observed atrophy in the rostral mesencephalic nucleus of the trigeminus, poorly 
pigmented neurons of the locus coeruleus, medial/inferior vestibular nuclei and medullary reticular 
formation, smaller medullary pyramids with gliosed dorsal portions; and gliosed Goll’s and 
Burdach’s nuclei.87, 88, 91 
 
Other pathological findings include neuroaxonal dystrophy in the medulla oblongata tegmentum, 
particularly in the gracilis and cuneatus nuclei.89, 97 Nuclei of the 5th, 6th, 7th and 12th cranial nerves 
have also been shown to display varying neuronal loss and gliosis.89 
 
Spinal Cord 
Pathology in lower motor neurons of the spinal cord is generally reported in A-T patients that live 
past their third decade.88, 96, 97 The earliest study to discuss spinal cord pathology in A-T reported 
severe spinal dorsal tract demyelination and fibrillary gliosis, especially in the cervical area and the 
cuneate and gracile fascicle. Proximal spinal root demyelination and fibrosis, focal necroses in the 
anterior spinal cord and abnormal grey matter (GM) structures in the cervical and lumbar spinal cord 
have also been recorded.93 Pallor regions and demyelination in the posterior spinal column have been 
described, particularly in the fasciculus gracilis, to a lesser degree in the fasciculus cuneatus, in the 
crossed pyramidal tracts and in dorsal spinocerebellar tracts.87-91, 94-97 Demyelination of the entire 
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posterior funiculi,92 the fasciculus proprius, the lateral corticospinal tracts89 and the gliosis of the 
anterior funiculi have also been recorded.88 Anterior horn cell degeneration in patients (30–40 years) 
has also been observed.87-92, 97, 100, 101 Other affected areas of the spinal cord are the dorsal root ganglia, 
with morphological and histological abnormalities that differ between individuals.88, 90, 94, 100 In 
peripheral nerves, extensive myelin and axon loss have been recorded in the sural, anterior tibial, 
femoral and sciatic nerves and cervico-brachial and lumbosacral plexus.87, 89 
 
A-T Neurodegeneration: Oxidative Stress 
As mentioned above, neurodegeneration in A-T is highly dependent on the age and individual patient. 
The primary cause of A-T neurodegeneration is the inability of the ATM protein to regulate oxidative 
stress levels in the cerebellum, leading to the apoptosis of oxidative stress sensitive Purkinje cells. 
Early studies using human and rodent models have shown that ATM protein expression is highest in 
the cerebellum,102, 103 particularly in the cytoplasm of Purkinje cells.104 Recent studies have shown 
ATM protein localisation to cerebellar Purkinje neuron nuclei in human brain tissue.105  
 
The earliest paper to report reactive oxygen species involvement in A-T describes G2 phase 
sensitivity to hydrogen peroxide in A-T cells.106 The ATM protein is a sensor of DNA damage and a 
regulator of cellular homeostasis under oxidative stress;69, 107 thus, ATM deficiency causes the build-
up of reactive oxygen species intermediates and Purkinje cell apoptosis due to these intermediates.108-
111 Purkinje cell degeneration is also attributed to the overproduction of nitric oxide (NO), which is a 
neurotransmitter to the cells.108 NO can react with the high levels of superoxide anions in ATM 
deficient cerebella103 to form the strong oxidant peroxynitrite,108, 112, 113 leading to an increase in 
cerebellar oxidative species and subsequent DNA and protein damage to Purkinje cells. 
 
To manage A-T neurodegenerative symptoms, investigation into therapies focusing on the use of the 
glucocorticoids dexamethasone and betamethasone have been undertaken.111, 114-121 In mouse models, 
dexamethasone has been found to inhibit redox activities in both thymocytes and splenocytes with or 
without Atm, arrest the cell cycle of Atm knockout thymic lymphoma cells at the G1 phase and cause 
apoptosis in ATM knockout thymocytes, preventing thymic lymphoma in mice.122-125 Of the two 
glucocorticoids, betamethasone has undergone preliminary clinical testing in A-T. In an early study, 
betamethasone was reported to improve neurological symptoms in a child diagnosed with A-T, 2 to 
3 days after initial treatment. This improvement continued 2 weeks into treatment, where ataxic stance 
and gait were reduced and head and neck control as well as skilled movement control were improved. 
At 4 weeks, the only adverse side effects were increased appetite, body weight and moon face; 
however, after 4 weeks, no beneficial effects were observed. At this point, drug therapy was switched 
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to the glucocorticoid methylprednisolone, and after 6 months without therapy, the child showcased 
severe impairment of the central nervous system. The serum α-fetoprotein level was unchanged 
during and after treatment.126 An extension of this study using six patients produced similar results.127 
A separate multi-centre, double-blind, randomised, placebo-controlled crossover trial using 13 A-T 
affected children and oral betamethasone and placebo also yielded a reduction of ataxia symptoms 
among A-T subjects.128 For these studies, cerebellar improvement and antioxidant increase was found 
to be drug dependent.128, 129 Lower doses of betamethasone (30% of what is given to patients) were 
found to be effective and result in milder steroid side effects; however, α-fetoprotein levels do not 
change.130  
 
These preliminary studies have demonstrated that improved response from betamethasone is 
associated with age, with younger patients showing better resolution of the clinical ataxia measures.127 
These findings suggest that a threshold level of cerebellar degeneration may be a prerequisite to 
successful steroid therapy in A-T.131, 132 Such a threshold level may be determined using non-invasive 
imaging with MRI, especially diffusion-weighted imaging, which enable the extent of degeneration 
of cerebellar–corticomotor pathways to be quantitatively assessed in a number of ataxic conditions.21-
28 
 
Interestingly, a recent fMRI pilot study where A-T patients received a 10-day cycle of oral 
betamethasone has shown increased activation within corticomotor regions after treatment using 
simple motor tasks.133 This preliminary work suggests that steroid treatment could improve motor 
performance, facilitating cortical compensatory mechanisms. Importantly, this pilot study gives 
evidence that non-invasive fMRI studies may be useful to monitor treatment effects. 
 
Summary of Radiological Findings in A-T 
Early work in understanding radiological changes associated with A-T involved the use of CT to 
detect cerebellar atrophy.134-137 These studies reported no cerebral, pons or cerebellar vermis 
atrophy;138 however, brainstem calcifications were observed in patients in their fourth decade.137 
Despite the high spatial resolution, such findings highlight the significant challenges of using CT to 
delineate subtle neuropathological changes associated with A-T (reviewed in Wick139). Limits to 
radiation dosimetry measures also impact on the use of CT to study A-T. MRI is the preferred imaging 
modality due to its high spatial resolution, superior soft tissue contrast affording exquisite detail of 
anatomical structures and lack of radiation. In addition, MRI can be employed in a serial fashion to 
not only target morphological changes but also measure physiologic parameters, including cellular 
diffusion140, 141 and permeability,142 making this modality ideally useful for neurological research. 
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To date, only 18 MRI studies focusing on A-T patients have been reported in the English language.84, 
133, 143-158 Further details of these studies are summarised in Table 2.1. In general, MRI findings in A-
T patients have reported cerebellar atrophy, specifically of superior cerebellar hemispheres or vermis, 
inferior cerebellar vermis hypoplasia, enlarged fourth ventricles and large cisterna magna, with 
variations among individuals.84, 143-145, 148, 150, 151, 153, 156, 158 These findings support post-mortem 
clinical observations, with slight differences in anatomical detail. As mentioned previously, post-
mortem studies have reported specific cerebellar pathology in the frontal and posterior vermis, in the 
middle and superior cerebellar peduncles of both cerebellar hemispheres87, 88, 90-98 and other 
generalised findings (see ‘Cerebellum’ section).87-89, 97, 98 These variations in post-mortem and 
radiological findings can be attributed to the genetic variation of ATM mutations in the A-T 
population, which further extend to the disease neuropathology such that A-T symptoms in the same 
anatomic region differ on a case-by-case basis. 
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Table 2.1. Summary of CT/MRI studies in A-T 
Reference Image type 
(CT/T1/T2/fMRI) 
Age Range (years) 
 
Gender 
(M/F) 
Major findings 
Huang and colleagues(84) N/A but possibly CT/T1 4-14 2/6 Findings: cerebellar atrophy via CT and MRI 
examinations. 
Quarantelli and 
colleagues(133) 
T1/T2/fMRI 7-17 2/2* Aim^: to test if steroid (betamethasone) induced 
motor performance changes in A-T is associated 
with fMRI modifications. 
Findings: increase in the number of activated 
voxels within the motor cortex under the on-
therapy condition compared with the cortical 
activity under baseline condition in two patients. 
Demaerel and 
colleagues(143) 
CT/T1/T2 3-22 3/2 Findings: cerebellar atrophy in four patients, with 
discrete calcification on CT in the lentiform 
nuclei, WM low density and cortical thickening 
consistent with pachygyria. Cerebellar atrophy 
detected in MRI in one patient. 
Farina and colleagues(144) CT/T1/T2 4-22 6/6+ Findings: cerebellar atrophy, decreased thickness 
of superior cortex of cerebellar hemispheres, 
hypoplasia of inferior vermis and large cisterna 
magna observed in A-T patients. 
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Sardanelli and 
colleagues(145) 
T1/T2/T2* 
 
9-28 5/0 Findings: vermian atrophy, enlarged fourth 
ventricles and cisterna magna noted in all patients. 
Four patients had cerebellar hemisphere atrophy 
and two had enlarged infracerebellar subarachnoid 
spaces. Diffuse symmetrical high signal seen in 
central WM of cerebral hemispheres on T2- 
weighted images of oldest patient. Brainstem and 
basal ganglia changes not seen. 
Ciemins and colleagues(146) T1/T2 31 0/1 Findings: multiple small foci of decreased WM 
observed. 
Opeskin and colleagues(147) T1/T2 34 1/0 Findings: gross cerebellar atrophy, lesions 
consistent with vascular malformations in cerebral 
WM with surrounding abnormal tissue consistent 
with gliosis found. MRI scans 6 months apart from 
the age of 32 years showed progression of lesions. 
Kamiya and colleagues(148) T1/T2 24 1/0 Findings: coagulated necrosis of brain WM and 
vascular abnormalities in the brain parenchyma 
found. 
Huang and colleagues(149) CT/T1/T2 7-8 1/1 Findings: in male A-T subject, MRI and CT 
revealed no abnormalities. Brain MR in female A-
T subject revealed cerebellar atrophy. 
57 
 
Tavani and colleagues(150) T1/T2 2-12; eldest: 
35 and 38 
10/9 Findings: 2-year-old was normal. In the five next 
youngest patients (3–7 years), lateral cerebellar 
and superior vermis atrophy were seen. Five 
patients who were unable to walk had diffuse 
atrophy in both the vermis and cerebellar 
hemispheres. 
Firat and colleagues(151) T1/T2 9-13 5/1 Findings: clear differences in cerebellar atrophy 
in A-T patients compared to controls. In early MRI 
diagnosis of A-T, diffuse atrophy of the superior 
cerebellar cortex was found. Cerebellar mean 
apparent diffusion coefficient (ADC) values of 
patients and controls were statistically different 
(p<0.011–0.0001). 
Lin and colleagues(152) T2/MR spectroscopy 9-27 3/5 Aim^: to measure regional metabolite levels in 
the posterior fossa and basal ganglia of A-T 
patients. 
Findings: in A-T, there was loss of all metabolites 
in the cerebellar vermis and decreased metabolites 
in the cerebellar hemispheres. No abnormalities in 
the basal ganglia were seen. 
Wallis and colleagues(153) T1/T2/T2*/MR 
spectroscopy 
23-47 7/5  Findings: cerebellar atrophy of vermis and 
hemispheres were observed in all A-T patients. 
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Cerebellar analysis revealed significantly lower 
NAA/Cho and higher Cho/Cr ratios in A-T 
compared to controls (N-acetylaspartate (NAA), 
choline (Cho), and creatine (Cr)). 
Habek and colleagues(154) T1/T2/T2* 34 0/1 Findings: extensive and diffuse WM 
demyelination, T1 and T2 hypointense lesions, T1 
hypointense but T2 hyperintense lesions and 
dilated telangiectases seen in A-T.  
Kieslich and colleagues(155) T1/T2 8–26 6/5 
 
Findings: marked hyperintense lesions in the 
cerebral WM of T2-weighted MR images and 
spinal atrophy and MRI abnormalities of the basal 
ganglia in one patient were found. MRI in patients 
with normal IGF-1 levels showed cerebellar 
lesions in four patients and spinal atrophy in only 
two patients. No affectation was seen of the 
cerebral WM or basal ganglia in this group. 
Al-Maawali and 
colleagues(156) 
T1/T2 Age of onset: 1-3 N/A Findings: isolated cerebellar atrophy in A-T MRI 
scans, with no extracerebellar findings. 
Chung and colleagues(157) T2 4 0/1 Findings: MRI scans showed 
leukoencephalopathy which matches 
leukodystrophy, a neuroimaging feature of A-T 
not described before. 
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* Two patients were excluded because of insufficient compliance.(133) 
+ One subject was a heterozygote parent.(144) 
^ Aims are listed in studies that were not entirely anatomy-based.
Lin and colleagues(158) T1/T2 19-34 4/6 Findings: manifest cerebellar atrophy was seen in 
A-T; supratentorial brain showed no sign of 
volume loss. Intracerebral telangiectasia with 
multiple punctate haemosiderin deposits were 
identified in 60% of subjects.  
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In addition, radiological and post-mortem studies involved patients at different progressive stages of 
the disease; thus, differences in A-T neuropathology between the two study modalities can be 
expected. 
 
T1- and T2-weighted images have shown multiple WM small foci of signal hypo-intensities in A-T 
patients, which were hypothesised to be haemosiderin areas related to haemorrhage from capillary 
telangiectasias or gliovascular nodules.146 Asymptomatic supratentorial vascular abnormalities in the 
cerebrum have also been reported in a recent study using 10 adult A-T patients, where intracerebral 
telangiectasia with multiple punctate haemosiderin deposits were identified in 60% of the imaged 
patients.158 These more recent findings reflect post-mortem observations of cerebral pathology in A-
T91, 92 with slight pathological differences due to individual patient differences and differences in the 
progressive stage of disease. 
 
The number of published MRI studies in A-T is limited; however, it can be seen that abnormal 
radiological findings reported from MRI were subtle for A-T patients until age 10; after which, 
cerebellar atrophy becomes more evident.150 However substantial variation in cerebellar atrophy with 
age does exist as evidenced in Figure. 2.1. In this case, significant cerebellar atrophy is clearly present 
in a 7-year-old child with A-T. Again, these observations may differ between case studies and 
between different A-T cohorts.  
 
Figure 2.1. Age-matched sagittal T1 and axial T2 MRI scans acquired from control (A, C) and A-T 
patients (B, D). The representative images have been acquired from 7- (A, B) and 23-year-old 
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participants (C, D). The A-T images show marked cerebellar atrophy with involvement of both 
hemispheres including the cerebellar vermis. 
 
The evolution of neuropathological changes in very young children with A-T is not well understood. 
One case study reported MRI findings of a 4-year-old child who was scanned at 17 months of age. 
The early images showed leukoencephalopathy compatible with leukodystrophy, a neuroimaging 
finding that has not been described in A-T.157 This eludes to the possibility of diffuse WM signal 
intensity on T2-weighted MRI,159 which indicates progressive demyelination may occur in the early 
stages of A-T. The specificity of this finding has yet to be established. MRI scans in older patients in 
their second and third decade also show varied findings in the cerebellar and cerebral lesion 
progression, such as corpora amylacea,147 diffuse symmetrical high signal in the central WM of 
cerebral hemispheres on T2- weighted images,145 scattered calcified deposits in the cerebrum WM 
and space occupying lesions in the right frontal lobe WM and left paraventricular WM.148, 154 Both of 
these lesions were displayed with low intensity on T1-weighted images and high intensity on T2-
weighted images.148 General spinal atrophy and abnormalities in the basal ganglia have also been 
reported in older A-T patients,155 supporting post-mortem spinal study findings in older A-T patients, 
but lacking specific anatomical detail (see ‘Spinal Cord’ section). 
 
Discussion 
Very few studies have focused on reporting radiological findings in A-T.133, 143-148, 150-157 Of these, 
studies using standard T1- and T2-weighted MRI sequences have consistently shown diffuse 
cerebellar atrophy, predominantly within the vermis and cerebellar hemispheres. This reflects the loss 
of Purkinje cells on a histological level, which is a well-established neuropathological hallmark of A-
T. Foci of T2-weighted WM hypo- and hyper-intensity have also been observed and attributed to 
capillary telangiectasia and focal extracerebellar demyelination.146 
 
While these morphological studies have been useful from a radiological perspective, they provide 
limited information regarding the association between neurodegeneration and the loss in integrity of 
neural motor networks. A growing body of work has demonstrated that diffusion-weighted MRI 
(dMRI), particularly diffusion tensor imaging (DTI), allows a more accurate depiction of the integrity 
of brain and brainstem structures than that afforded by standard MRI.16  
 
An extension of dMRI is the use of fibre tracking to delineate WM fibre bundles in the brain. The 
advantage of this approach is that the integrity of specific WM tracts in conjunction with the 
connectivity of pathways linking multiple brain regions can be assessed.160, 161 Such technology has 
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been applied to study cerebellar–corticomotor networks in a number of ataxic conditions.21-28 A recent 
study in particular has observed cerebello-cerebral WM connectivity disruptions in Friedreich’s 
ataxia with diffusion MRI, tractography and super-resolution track density imaging, which has 
explained some of the non-ataxic symptoms observed with this disease.162 To date, there are no 
published studies investigating degeneration of cerebellar–corticomotor tracts using WM fibre 
tracking in A-T. Future work using this modality needs to be directed towards understanding the 
spatial extent of degeneration along each WM pathway, specifically in terms of the connectivity 
between the cerebellum and cerebrum, to ascertain whether degeneration occurs predominately 
within the cerebellum and propagates to cerebral regions or occurs along the entire length of the 
cortico-cerebellar motor pathway. Such studies are urgently required to fully understand the impact 
of mutation of the ATM gene and loss in connectivity of motor circuits in A-T. 
 
Future studies should also investigate the degeneration of motor pathways involving subcortical 
structures such as the basal ganglia, which are known to be involved with motor disorders. Although 
basal ganglia pathology has been associated with mutation of the ATM gene,92 it is currently not 
known whether striatal–corticomotor pathways are affected in A-T. The integrity of such motor 
networks is of interest due to a recent study reporting improved neurological measures in A-T patients 
after treatment with amantadine sulphate.163 Although the mechanism of amantadine is not well 
understood, it is believed to act on striatal dopaminergic systems.164, 165 Future work should also focus 
on the relationship between clinical measures and the integrity of motor pathways to develop useful 
biomarkers for monitoring disease progression and assessing the efficacy of new therapies. 
 
Our understanding of the very early neuropathological changes in A-T is limited. Imaging data from 
infants with A-T is extremely difficult to acquire due to delayed onset of clinical phenotypes, and 
thus, we can only speculate on the integrity of the WM and GM areas, particularly those associated 
with the cerebellum, which may be compromised at the very early stages of development. Obtaining 
imaging data from an infant cohort would be extremely beneficial but rather challenging due to the 
difficulty and complexity of gaining an early diagnosis of A-T. Nonetheless, such information may 
shed light on the neurodevelopmental origins of A-T. 
 
Conclusion 
The various clinical, genetic and immunological aspects of A-T have been reported extensively in 
past literature, with imaging studies in A-T using CT and MRI to report predominately radiological 
anomalies. Little attention has been directed towards identifying altered brain structure and function 
using dMRI, and as such, there are no published studies investigating degeneration of cerebellar–
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corticomotor tracts using WM fibre tracking in A-T to date. Future work in A-T using dMRI will 
assist in understanding the spatial extent of degeneration along each WM pathway, specifically the 
connectivity between the cerebellum and cerebrum, to ascertain whether degeneration occurs 
predominately within the cerebellum and propagates to cerebral regions or occurs along the entire 
length of the cortico-cerebellar motor pathway. Such studies are a key first step to fully understand 
the impact of mutation of the ATM gene and loss in connectivity of motor circuits in A-T. 
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CHAPTER 3 
 
Altered Corticomotor-Cerebellar Integrity 
in Young Ataxia-telangiectasia Patients 
 
This chapter includes the second manuscript published during PhD candidature in Movement 
Disorders, 2014. The paper details grey and white matter imaging conducted between A-T patients 
and healthy control participants, under the first aim of the PhD project, to: ‘assess whole brain cortex 
and subcortical WM and GM morphological changes between A-T patients and typically developing 
participants’.  
 
The paper highlights the whole brain methodology involved in uncovering these changes between 
control and patient groups and presents the voxel-wise WM and GM changes that are seen in young 
A-T patients compared to controls. In addition, clinical scoring details of each A-T patient are 
included in the paper to provide a comprehensive picture of heterogeneous neurodegeneration and 
ataxic symptomology in A-T.  
 
As first author of this paper, I collected, analysed and interpreted the data and drafted and edited the 
manuscript. My co-authors Stephen Rose and Kerstin Pannek contributed to data collection and the 
interpretation of results. My co-authors Kate Sinclair, Simona Fiori and Martin Lavin contributed to 
the clinical interpretation of results. All co-authors provided critique of the article. 
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Abstract  
Magnetic resonance imaging (MRI) research in identifying altered brain structure and function in 
ataxia-telangiectasia, an autosomal recessive neurodegenerative disorder, is limited. Diffusion-
weighted MRI were obtained from 11 ataxia-telangiectasia patients (age range, 7-22 years; mean, 12 
years) and 11 typically developing age-matched participants (age range, 8-23 years; mean, 13 years). 
Grey matter volume alterations in patients were compared with those of healthy controls using voxel-
based morphometry, whereas tract-based spatial statistics was employed to elucidate white matter 
microstructure differences between groups. White matter microstructure was probed using 
quantitative fractional anisotropy and mean diffusivity measures. Reduced grey matter volume in 
both cerebellar hemispheres and in the precentral-postcentral gyrus in the left cerebral hemisphere 
was observed in ataxia-telangiectasia patients compared with controls (p<0.05, corrected for multiple 
comparisons). A significant reduction in fractional anisotropy in the cerebellar hemispheres, 
anterior/posterior horns of the medulla, cerebral peduncles, and internal capsule white matter, 
particularly in the left posterior limb of the internal capsule and corona radiata in the left cerebral 
hemisphere, was observed in patients compared with controls (p<0.05). Mean diffusivity differences 
were observed within the left cerebellar hemisphere and the white matter of the superior lobule of the 
right cerebellar hemisphere (p<0.05). Cerebellum-localised grey matter changes are seen in young 
ataxia-telangiectasia patients along with white matter tract degeneration projecting from the 
cerebellum into corticomotor regions. The lack of cortical involvement may reflect early-stage white 
matter motor pathway degeneration within young patients.  
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Introduction  
Ataxia-telangiectasia (A-T) is an autosomal recessive neurodegenerative disorder that occurs in 1 per 
88,000 live births in the United States67 and in approximately 3 per million live births in the United 
Kingdom.1 Multi-system disease characteristics are attributed to genetic mutation of the ATM (ataxia-
telangiectasia mutated) gene2, 3 and include progressive cerebellar ataxia, immunodeficiency, 
sinopulmonary infections, oculocutaneous telangiectasia,4, 5 and elevated serum alpha-fetoprotein 
levels.6 The ATM gene encodes the protein kinase ATM, a key player in the cellular response to DNA 
double-stranded breaks.7, 8 This protein is also involved in the response to oxidative damage, ATM 
activation by oxidative stress,9 and it may have a more general role in cell homeostasis. Once 
activated, ATM phosphorylates a multitude of proteins that control various cellular processes, 
including different cell cycle checkpoint pathways.10 Mutation of this gene is linked to increased 
radiosensitivity in A-T patients11, 12 and in cells from these patients in culture.13, 14 Lymphoreticular 
malignancy or recurrent chronic respiratory infections4, 5 is the cause of death in most patients. 
 
To date, imaging studies using conventional T1- and T2-weighted magnetic resonance imaging (MRI) 
have been used to highlight the hallmark neuropathological features associated with A-T, namely 
progressive cerebellar atrophy.84, 144, 148, 150, 158 Although this has been useful from a radiological 
perspective, such morphological studies provide limited information of the association between 
neurodegeneration and the loss in neural motor network integrity. Diffusion-weighted MRI (dMRI), 
particularly diffusion tensor imaging (DTI), has been demonstrated to allow a more accurate depiction 
of brain and brainstem structure integrity than that afforded by standard MRI.16  
 
In contrast to conventional MRI, DTI measures the random motion of water in cerebral tissue. When 
this random motion is preferentially restricted to movement in one direction, as occurs along axonal 
bundles, such diffusion is referred to as anisotropic. Fractional anisotropy (FA) is a quantitative 
measure of the degree of anisotropy, and mean diffusivity (MD) measures the mean motion of water 
considered in all directions. White matter (WM) fibre degeneration is typically reflected by decreases 
in FA, and increases in MD (reviewed in Beaulieu37). These measures are used to interrogate 
pathological changes in regard to myelination, in cerebral tissue.57 A number of elegant approaches 
have been developed that enable the voxel-wise analysis of diffusivity measures (FA and MD), such 
as tract-based spatial statistics (TBSS).42, 44 Furthermore, grey matter (GM) volume can be assessed 
using voxel-based morphometry (VBM).40, 41 Such analysis strategies have yet to be applied in A-T 
clinical populations. 
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Within the research setting, diffusion imaging studies of children with ataxias presents a significant 
challenge. The most prominent challenge is the presence of excessive image artefacts caused by 
uncontrolled head motion during non-sedated scanning procedures on diffusion-weighted images. 
These technical issues have in part been addressed through a series of data pre-processing and 
correction steps to reduce image distortions inherent to the acquisition technique, as well as those 
caused by involuntary head movement,20 allowing dMRI studies to be performed in A-T. Such studies 
are urgently needed to fully elucidate the relationship between mutation of the ATM gene and loss in 
the integrity of motor circuitry. The aim of this paper is to highlight the potential of WM and GM 
imaging, by demonstrating that DTI can be performed successfully on children with A-T. We present 
novel findings depicting the loss in integrity of key cerebellar-corticomotor pathways with respect to 
normal brain development in A-T. 
 
Methods 
Participants 
Magnetic resonance imaging data were acquired from 11 patients with A-T (6 male: age mean ± SD, 
12.18±5.56; age range, 7-22 years) and 11 age-matched typically developing participants (4 male: 
age mean ± SD, 12.82±5.51; age range, 8-23 years). All of the patients have been clinically diagnosed 
for human A-T in accordance with the recent World Health Organisation recommendations,166 
including genetic testing. All subjects and parents gave informed consent in accordance with our 
Human Ethics Institutional Review Board and the Declaration of Helsinki. 
 
Clinical Scoring 
The clinical scoring of A-T patients was conducted using a modified version of the A-T Neuro 
Examination Scale Toolkit (A-T NEST), an A-T scaling system that has been refined from a 
quantitative 10-point scale since its introduction in 2000.167 The modified A-T NEST accounts for 
the multi-dimensional nature of A-T characteristics and compensates for the disease’s complexity 
and heterogeneity, making for an effective and sensitive method to precisely measure A-T 
neurological deficits (personal communication with Dr. Thomas Crawford, Professor of Neurology 
and Paediatrics at the John Hopkins Hospital). 
 
Image Acquisition 
Imaging data were acquired using a 3T MRI scanner (Siemens Trio, Erlangen, Germany) with TQ 
gradients (45 mT/m, slew rate 200 T/m/s), using a 12-element Tim head array. A high-resolution 
structural image was acquired using a 0.9 mm isotropic 3D T1 Magnetisation Prepared Rapid 
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Gradient Echo (MPRAGE) sequence. The imaging parameters were: field of view, 23×23×17.3 cm; 
TR/TE/TI 1,900/2.32/900 ms; flip angle, 9 degrees; matrix size, 192×512×512×1 cm. Diffusion MRI 
acquisition consisted of a high angular resolution diffusion imaging (HARDI) sequence with the 
following parameters: 60 axial slices; 2.5 mm slice thickness; field of view 30×30 cm; TR/TE 
9500/116 ms; acquisition matrix 128×128, resulting in an in-plane resolution of 2.34×2.34 mm. 
Parallel imaging with an acceleration factor of 2 was employed to reduce susceptibility distortions. 
Sixty-four diffusion-weighted images were acquired at b=3,000 s mm-2, along with one minimally 
diffusion-weighted image (b=0). The acquisition time for the diffusion dataset was 9:40 minutes. A 
field map for diffusion data was acquired using two 2-dimensional gradient-recalled echo images (36 
axial slices; 3 mm slice thickness with 0.75 mm gap; field of view 19.2×19.2 cm; TR/TE1/TE2 
488/4.92/7.38 ms; acquisition matrix 64×64) to assist correction for distortions caused by 
susceptibility inhomogeneity. 
 
Diffusion Processing 
An extensive pre-processing procedure was followed to detect and correct for image artefacts caused 
by head motion and image distortions,20 thereby enabling the use of all patient subjects for analysis. 
Image volumes affected by within-volume movement were detected using the discontinuity index168 
and excluded from further analysis. Image distortions caused by susceptibility inhomogeneities were 
reduced using the field map, using tools available with FMRIB’s Software Library (FSL169). Intensity 
inhomogeneities were removed using N3.170 Subsequently, signal intensity outlier voxels (caused by 
cardiovascular pulsation, bulk head motion, and so forth) were detected and replaced using the 
detection and replacement of outliers prior to resampling (DROP-R) approach.171 This involves 
between-volume registration to account for head movement during the scan time using a fit model to 
all measurements (FMAM) method,172 including adjustment of the b-matrix.173, 174 DROP-R was 
modified from the originally proposed method to employ a model for the detection and replacement 
of outliers termed higher order model outlier rejection (HOMOR175). FA and MD maps were then 
generated using the MRtrix package.59 
 
Tract-Based Spatial Statistics 
To investigate WM degeneration between A-T patients and healthy controls, WM microstructure was 
compared by carrying out voxel-wise statistical analysis of the FA and MD data using TBSS,44 part 
of FSL.42 After alignment of all subjects’ FA data into FMRIB58 FA standard space using the 
nonlinear registration tool FNIRT,176, 177 the mean FA image was created and thinned to create a mean 
FA skeleton representing the centres of all tracts common to the group. The aligned FA data of each 
subject was projected onto this skeleton and the resulting data fed into voxel-wise cross-subject 
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statistics. Permutation based testing (independent samples t-test) was carried out using the 
‘randomise’ program included in FSL, which also corrected for multiple comparisons in space, using 
threshold-free cluster enhancement with 5,000 iterations.178 Sex was included as a covariate in the 
analysis. Structures with significantly different FA or MD between subject groups (p<0.05) were 
identified using the John Hopkins University WM atlases included in FSL.179 
 
Voxel-Based Morphometry 
Grey matter changes between A-T subjects and healthy controls were analysed with FSL-VBM,40 an 
optimised VBM protocol41 carried out with FSL tools.42 No A-T subjects were excluded from the 
analysis based on visual assessment of images for head motion artefacts. Structural images were first 
brain-extracted and GM segmented before being nonlinearly registered to the Montreal Neurological 
Institute (MNI) 152 standard space.177 A left-right symmetric, study-specific GM template was 
created using the resulting images, which were averaged and flipped along the x-axis. All native GM 
images were then nonlinearly registered to this study-specific template and ‘modulated’ for local 
expansion (or contraction) correction because of the nonlinear component of the spatial 
transformation. Smoothing with an isotropic Gaussian kernel with a sigma of 3 mm was applied to 
the modulated GM images. A statistical voxel-wise analysis (independent samples t-test) was then 
performed, using permutation based nonparametric testing with 5,000 iterations, adjusted for multiple 
comparisons across space, using threshold-free cluster enhancement.178 Sex was included as a 
covariate in the analysis. Voxels were considered significant at corrected p<0.05. We use the 
terminology GM volume, which refers to the likelihood of GM within a voxel, not a physical property 
of the underlying GM. 
 
Results 
Clinical and T2-Weighted MRI Observations 
T2-weighted MRI axial scans revealed cerebellar atrophy without major pathological conditions in 
the cerebrum of A-T patients used in this study. WM hyper-intensity and telangiectasias (thickening 
of blood vessels) were not present on T2-weighted MRI (Figure 3.4, Appendices). Overall, clinical 
observations indicate heterogeneity of A-T characteristics among patients. Ataxia, movement 
disorder, and neuropathy were highly individualised in each subject, irrespective of age. Indeed, in 
the clinical scoring of the A-T cohort, three young patients displayed marked/mixed neuropathy, with 
a loss of ankle, knee, and bicep tendon reflexes and loss of proprioception in toes (Patients 2, 7, and 
9, 7-10 years of age, Table 3.1), indicating advanced WM degeneration at a young age in the cohort. 
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Table 3.1. Summary of clinical observations of A-T patients 
Patient Age A-T Nest Score Observed symptoms 
1 16 Eye movements: 6/30a  
Ataxia: 7/28 
Movement Disorder:  
2/6 Bradykinesia 
16/16 Hyperkinesia 
8/12 Dystonia 
Neuropathy: N/Ab 
 
Eye movements: off-foveal gaze tendency 
(vertical or horizontal) is frequent and persistent. 
Nystagmus on lateral gaze unsustained. 
Ataxia: sitting requires no support but sways 
slightly. Standing needs total vertical support. 
Walking requires vertical support. 
Movement Disorder: hypomimea (dystonic) 
facial expression and abnormal persistence of large 
facial expressions. Limb posturing dystonia present 
with either social/cognitive or motor activation. 
Neuropathy: absence of ankle tendon, bicep 
tendon and knee tendon reflexes. Normal 
proprioception in toes. 
2 7 Eye movements: 22/30a  
Ataxia: 20/28 
Movement Disorder: 
3/6 Bradykinesia 
13/16 Hyperkinesia 
N/A Dystonia 
Neuropathy: N/Ab  
Ataxia: sitting requires no support but sways 
slightly. Stands with feet together but sways. 
Walking has the normal path width without 
corrective steps. 
Neuropathy: absence of ankle tendon reflexes. 
Presence of bicep tendon and knee tendon reflexes. 
Proprioception in toes and vibration sense at ankles 
present. 
3 12 Eye movements: 9/18 
Ataxia: 8+/26 
Movement Disorder: 
3.5/8 Bradykinesia 
6/15 Hyperkinesia 
10/14 Dystonia 
Neuropathy: N/Ab 
 
Eye movements: oculo-motor apraxia sometimes 
observed.  
Ataxia: sits with self-support of arms. Standing 
requires no support but takes corrective steps. 
Walking requires massive lateral support.  
Movement Disorder: Retro-Colic spasms with 
motor or stance activation observed. Hypomimea 
(dystonic) facial expression present. Head/trunk 
posturing/tilt/turn mild at rest and mild with 
movement/posture. Trunk posturing/tilt/turn mild 
at rest and normal with movement/posture. 
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4 9 Eye movements: 19/30 
Ataxia: 14/28 
Movement Disorder:  
1/6 Bradykinesia 
10/16 Hyperkinesia 
7/11 Dystonia 
Neuropathy: N/Ab 
 
Eye movements: off-foveal gaze tendency 
(vertical or horizontal) present only with certain 
activities. Oculo-motor apraxia present on most 
(>50%) gaze shifts. Post-rotary nystagmus persists 
more than 10 seconds. Period alternating 
nystagmus present. 
Ataxia: sitting requires no support but sways 
markedly. Standing takes no support but takes 
corrective steps. Walking requires no support but 
wide base or corrective stagger steps taken. 
Movement Disorder: distal/hand tremor present at 
rest. Proximal (face/head/trunk) tremor present at 
rest. Hypomimea (dystonic) facial expression 
present with abnormal persistence of large facial 
expressions.  
Neuropathy: normal with proprioception in toes, 
where movement sensibility is intact.  
5 7 Eye movements: 29/30 
Ataxia: 18/28 
Movement Disorder:  
2/6 Bradykinesia 
10/16 Hyperkinesia 
7/11 Dystonia 
Neuropathy: 6/6 
(Normal) 
Eye movements: off-foveal gaze tendency 
(vertical or horizontal) present only with certain 
activities. 
Ataxia: sitting requires no support but sways 
slightly/occasionally. Stands with feet together but 
slight sway. No support required while walking. 
Walks with normal speed with mild path deviations 
or corrective steps.  
Movement Disorder: face/head/trunk/distal limb 
tremor present at rest. Hypomimea (dystonic) facial 
expression present with abnormal persistence of 
large expressions. 
6 21 Patient had no clinical 
attendance. 
Patient had no clinical attendance. 
7 10 Eye movements: 17/30 
Ataxia: 6/28 
Movement Disorder:  
Eye movements: off-foveal gaze tendency 
(vertical or horizontal) present only with certain 
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2/6 Bradykinesia 
6/16 Hyperkinesia 
8/11 Dystonia 
Neuropathy: N/Ab 
 
activities. Oculo-motor apraxia present on all gaze 
shifts. 
Ataxia: sitting requires no support but sways 
markedly. Standing requires lateral support. 
Walking requires massive lateral support.  
Movement Disorder: face/head/trunk/distal limb 
tremor present with both social/cognitive and 
motor activation. Hypomimea (dystonic) facial 
expression present with abnormal persistence of 
large expressions. Head/trunk posturing present 
with either social/cognitive or motor activation. 
Neuropathy: absence of ankle tendon, bicep 
tendon and knee tendon reflexes. 
8 15 Eye movements: 20/30 
Ataxia: 7/28 
Movement Disorder: 
1/6 Bradykinesia 
13/16 Hyperkinesia 
6/11 Dystonia 
Neuropathy: N/Ab 
 
Eye movements: horizontal nystagmus 
unsustained. Nystagmus on lateral gaze 
unsustained. Off-foveal gaze tendency (vertical or 
horizontal) present only with certain activities. 
Oculo-motor apraxia present on most (>50%) gaze 
shifts. Post-rotary nystagmus persists more than 10 
seconds.  
Ataxia: sitting requires no support but sways 
markedly. Standing requires vertical support. 
Walking requires vertical support.  
Movement Disorder: face/head/trunk tremor 
present with both social/cognitive and motor 
activation. Hypomimea (dystonic) facial 
expression present with abnormal persistence of 
large expressions. Limb posturing present with 
both social/cognitive and motor activation. 
Head/trunk posturing present with either 
social/cognitive or motor activation. 
Neuropathy: absence of ankle tendon, bicep 
tendon and knee tendon reflexes. Proprioception in 
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toes have movement sensibility intact. Some 
vibration sense present in ankles.  
9 7 Eye movements: 16/30a 
Ataxia: 19/28  
Movement Disorder: 
4/6 Bradykinesia 
10/14a Hyperkinesia 
8/12 Dystonia 
Neuropathy: 1.5/6  
Ataxia: sitting requires no support but sways 
slightly. Stands with feet together but sways. 
Walking requires no support. Walks at normal 
speed with mild deviations in path or corrective 
steps.  
Movement Disorder: hypomimea (dystonic) 
facial expression present with abnormal persistence 
of large expressions. Head posturing and limb 
posturing present with either social/cognitive or 
motor activation. 
Neuropathy: presence of knee tendon reflexes. 
Absence of ankle tendon reflexes. Proprioception 
in toes is not completely absent (between scores 0 
and 1). 
10 22 Eye movements: 6/30 
Ataxia: 5/28  
Movement Disorder:  
2/6 Bradykinesia 
8/16 Hyperkinesia 
3/12 Dystonia 
Neuropathy: N/Ab 
 
Eye movements: sustained horizontal nystagmus. 
Sustained nystagmus on lateral gaze. Off-foveal 
gaze tendency is frequent and persistent. Oculo-
motor apraxia is present on all gaze shifts. Post-
rotary nystagmus persists more than 10 seconds. 
Ataxia: sitting requires no support but sways 
slightly. Standing needs support. Walking requires 
vertical support.  
Movement Disorder: distal limb movement 
present at rest. Face/head/trunk tremor present with 
both social/cognitive and motor activation. 
Hypomimea (dystonic) facial expression present 
with abnormal persistence of large expressions. 
Head posturing and limb posturing present with 
both social/cognitive and motor activation. 
Neuropathy: absence of ankle tendon, bicep 
tendon and knee tendon reflexes. Scored 3 on 
proprioception and 1 on vibration sense (because 
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proprioception is unreliable), showing that some 
vibration sense at ankles is intact. 
11 8 Eye movements: 21/30 
Ataxia: 7/28a  
Movement Disorder:  
2/6 Bradykinesia 
N/Ab Hyperkinesia 
N/Ab Dystonia 
Neuropathy: 6/6 
(normal)  
Eye movements: nystagmus on lateral gaze 
unsustained. Oculo-motor apraxia occasionally 
present. Post-rotary nystagmus persists more than 
10 seconds. Periodic alternating nystagmus 
present.  
Ataxia: sitting requires no support but sways 
markedly. Standing requires no support but takes 
corrective steps. Walking requires some lateral 
support. 
 
a Not all clinical tests were completed. 
b Scores are absent/were not recorded. 
 
Grey Matter Analysis 
The VBM analysis revealed areas of reduced GM volume in both the cerebellar hemispheres of the 
A-T subjects compared with the control participants (p<0.05) (Figure 3.1). GM changes were also 
present in the precentral-postcentral gyrus in the left cerebral hemisphere, indicating possible 
extension of GM degeneration to the cerebrum. The dentate nucleus was not part of the GM map and 
was not included in the analysis. The observed changes do not reflect progression of GM degeneration 
with age and are comparisons made from grouped data from control and A-T data sets.  
 
 
75 
 
 
Figure 3.1. Axial (A) and coronal (B) view of voxels with significantly reduced grey matter (GM) 
volume in ataxia-telangiectasia subjects compared with healthy participants. Data are shown at axial 
and coronal slices of GM template, at Y and Z coordinates as labelled. 
 
White Matter Analysis 
The TBSS analysis showed a significant reduction in FA in a number of WM tracts in the A-T subjects 
compared with the control participants. As shown in Figure 3.2, these regions included the cerebellar 
hemispheres, anterior/posterior horns of the medulla, cerebral peduncles, and WM of the internal 
capsule, particularly involving the left posterior limb of the internal capsule and corona radiata in the 
left cerebral hemisphere (p<0.05); see Table 3.2 for a summary of imaging findings. Differences in 
MD were observed within the left cerebellar hemisphere and the WM of the superior lobule of the 
right cerebellar hemisphere (p<0.05) (Figure 3.3). Significant loss in integrity of cerebellar WM and 
degeneration of WM tracts projecting from the cerebellum into corticomotor regions is collectively 
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seen. The observed changes do not reflect progression of WM degeneration with age and are 
comparisons made from grouped data from control and A-T data sets. 
 
Figure 3.2. Axial (A) and coronal (B) view of voxels with significantly reduced fractional anisotropy 
(FA) in ataxia-telangiectasia subjects compared with healthy participants. Data are shown at labelled 
MNI-152 Y and Z coordinates overlaid on the mean FA map. Mean FA skeleton is shown in green.  
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Table 3.2. Regions that were significantly abnormal in patients with A-T (n=11) compared with controls (n=11) after 
correction for multiple comparisons 
DTI Parameters MNI coordinates Cluster size 
(voxels) 
p-value Corresponding white matter cortical label (JHU-ICBM-DTI-81 white-
matter labels atlas) 
 x y z    
Reduced FA x = 129 y = 110 z = 103 7 0.05 Superior longitudinal fasciculus L 
 x = 116 y = 106 z = 96 315 0.043 Superior corona radiata L 
 x = 111 y = 136 z = 95 3482 0.023 Superior fronto-occipital fasciculus (could be a part of anterior internal 
capsule) L 
 x = 116 y = 102 z = 95 315 0.043 Posterior corona radiata L 
 x = 116 y = 102 z = 90 315 0.043 Posterior limb of internal capsule L 
 x = 112 y = 137 z = 90 3482 0.023 Anterior limb of internal capsule L 
 x = 119 y = 112 z = 90 315 0.043 External capsule L 
 x =121 y = 67 z = 89 83 0.048 Posterior thalamic radiation (include optic radiation) L 
 x = 118 y = 94 z = 87 315 0.043 Retrolenticular part of internal capsule L 
 x = 75 y = 117 z = 69 107 0.045 Posterior limb of internal capsule R 
 x = 76 y = 117 z = 67 107 0.045 Cerebral peduncle R 
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 x = 106 y = 112 z = 67 3482 0.023 Cerebral peduncle L 
 x = 95 y = 95 z = 56 3482 0.023 Superior cerebellar peduncle L 
 x = 99 y = 73 z = 51 3482 0.023 Inferior cerebellar peduncle L 
 x = 99 y = 104 z = 50 3482 0.023 Corticospinal tract L 
 x = 79 y = 76 z = 49 14 0.05 Inferior cerebellar peduncle R 
 x = 85 y = 82 z = 49 254 0.041 Superior cerebellar peduncle R 
 x = 84 y = 93 z = 47 254 0.041 Medial lemniscus R 
 x = 104 y = 102 z = 47 3482 0.023 Middle cerebellar peduncle 
 x = 97 y = 92 z = 47 3482 0.023 Medial lemniscus L 
 x = 95 y = 94 z = 37 3482 0.023 Pontine crossing tract (a part of MCP) 
Increased MD x = 109 y = 74 z = 43 1402 0.009 Middle cerebellar peduncle 
 x = 79 y = 78 z = 51 224 0.032 Inferior cerebellar peduncle R 
 x = 96 y = 75 z = 50 1402 0.009 Inferior cerebellar peduncle L 
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Figure 3.3. Axial (A) and coronal (B) view of voxels with significantly different mean diffusivity 
(MD) between healthy and ataxia-telangiectasia subjects. Data are shown at labelled MNI-152 Y and 
Z coordinates overlaid on the mean FA map. Mean FA skeleton is shown in green.  
 
Discussion 
Diffusion-weighted MRI, the method of choice for investigating cerebellar WM degeneration 
associated with multi-spectrum ataxic disorders,22, 25, 28 has not yet been extended to the study of A-
T. An important outcome of the current study is to highlight that, with use of an appropriate analysis 
pipeline, it is possible to study the WM microstructure of key cerebellar-corticomotor pathways 
within a sizeable A-T patient age range. Furthermore, voxel-wise TBSS and VBM analyses enabled 
delineation of WM and GM changes in the cerebrum and cerebellum of A-T subjects compared with 
control participants that are similar to neuropathological features reported in post-mortem studies.87, 
88, 91-93, 96, 97 The novel finding from this study identifies the degeneration of important cerebellar-
corticomotor pathways responsible for coordinated motor function in all A-T patients analysed. The 
results of the VBM analysis demonstrate that GM changes are localised primarily to the cerebellum 
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in these patients. Note that our analysis consisted of young children with A-T, in whom, generally, 
GM changes are rarely seen.88, 93, 96, 97 Serial qualitative analysis of high-resolution MRI data was not 
performed in this study and so trajectories of GM changes with age is yet to be established in A-T. In 
addition, correlation of VBM results with clinical scores was not performed, because scoring was 
incomplete (Table 3.1). Additional studies using VBM should focus on the inclusion of older A-T 
patients (late second decade and older), with appropriate age- and sex-matched control participant 
data, to provide a more comprehensive insight of GM changes with age. We predict more pronounced 
GM changes would be observed in an older A-T cohort, as suggested from reported post-mortem 
findings.93 
 
In terms of WM, we show changes associated with a number of cerebellar-corticomotor pathways, 
predominately within the left hemisphere in our A-T subjects. The localisation of changes to the 
dominant hemisphere is not clear. Post-mortem studies, in general, have not focused on 
neurodegenerative laterality. In one study, haemorrhagic lesions in left occipital WM were recorded 
in a 26-year-old male A-T patient.91 In a recent similar study of Friedreich’s ataxia using TBSS and 
VBM, increased MD was observed in the WM underlying the left central sulcus, among other general 
findings. A decrease in FA in the left superior cerebellar peduncle correlated with clinical severity.180 
Whether the localised WM changes in the left hemisphere are cohort specific or reflect more early 
degenerative changes in young A-T patients is unclear. Despite clinical observations of extensive 
WM neurodegeneration in young A-T sufferers in our study cohort, no clear correlation has been seen 
between this clinical observation and our imaging findings. 
 
We also show a significant reduction in FA in the cerebral peduncles and WM of the internal capsule, 
particularly involving the left posterior limb of the internal capsule and corona radiata in the left 
cerebral hemisphere in A-T patients. These findings were not reflected in structural T2-weighted axial 
scans (Figure 3.4, Appendices), indicating the sensitivity and specificity of dMRI for delineating WM 
degeneration. Our radiological findings in general do not reflect past imaging observations in cerebral 
pathological conditions in A-T.158 As seen from clinical observations of our A-T cohort, A-T 
neuropathology can be heterogeneous in nature among different patients, irrespective of age;82-84 
therefore, disease characteristics may differ from cohort to cohort. 
 
Multisite studies with larger cohorts of A-T subjects may provide improved insight into the 
degeneration of WM pathways and the neurological variability associated with the disease. To 
broaden our perspective of the impact of mutation in the ATM gene, the temporal trajectories of WM 
and GM changes with age should be further investigated, particularly in older patients, because this 
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important information is yet to be established in A-T. In addition to this, serial evaluation of WM and 
GM changes with age in individual A-T subjects should be investigated in the future to understand 
whether these changes are caused by degeneration or delayed WM and GM maturation. Together, 
with VBM results, our TBSS findings support a mechanism of degeneration within the cerebellum, 
propagating to corticomotor regions along the length of the cortico-cerebellar motor pathways. 
 
Future studies should also investigate degeneration of motor pathways that involve subcortical 
structures such as the basal ganglia, which are known to be involved with motor disorders. Basal 
ganglia pathological conditions were not explicitly seen in our study, despite the array of A-T 
characteristics observed in our clinical observations (Table 3.1); however, abnormalities in this 
structure have been previously recorded both in post-mortem study92 and in radiological findings,155 
particularly in older patients. As we have already mentioned, our particular A-T cohort consisted of 
very young patients; therefore, future work in A-T should include older A-T subjects as well as 
younger patients to provide an age-specific timeline of neuropathology in A-T. 
 
This study has a number of limitations, the foremost being the small number of A-T participants to 
undergo analysis and impact on our findings. Australia has seen fewer than 50 cases of A-T overall,181 
with our clinic being the only research clinic nationally, specialising in health care for 11 of those A-
T patients, representing 22% of the national population. The group-wise analysis strategies employed 
in this study also make it difficult to fully understand the heterogeneity of patterns of degeneration 
across A-T subjects. In our clinic, we observed heterogeneity of movement disorders in each patient 
(Table 3.1), which suggests that A-T affects not only cerebellar tracts but many other motor circuits. 
The extent of multiple affected areas of the brain and their sequence of development will only be 
realised with much larger collaborative studies across multiple research sites.182 
 
Future dMRI studies could also employ probabilistic tractography to delineate WM fibre tracts, to 
allow the connectivity and integrity of specific WM pathways linking multiple brain regions to be 
assessed.160, 161 Such technology has been used in a number of ataxic conditions to study cerebellar-
corticomotor networks22, 25, 28 and are urgently required to fully understand the impact of ATM gene 
mutation and loss in connectivity of A-T motor circuits. 
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CHAPTER 4 
 
Motor pathway degeneration in young 
ataxia-telangiectasia patients: A diffusion 
tractography study 
 
This chapter includes the third manuscript published during PhD candiature in NeuroImage Clinical 
in 2015. The paper details diffusion tractography and along tract analysis of corticomotor cerebellar 
and corticospinal motor tracts in A-T patients and healthy control participants, under the second aim 
of the PhD project, to ‘investigate if A-T neuropathy is localised to the cerebellum or extends to the 
entire motor cortex in select WM pathways in A-T’.  
 
The paper highlights the ability to compute WM integrity quantitatively (FA and MD) at consistent 
intervals along tract length to provide a comprehensive view of WM microstructure variation by brain 
region in A-T patients. In addition, general degeneration, identification of structural differences and 
assessment of connectivity between cerebral and cerebellar regions of selected A-T motor tracts were 
assessed in this paper using WM tract streamline count, tract volume and apparent fibre density 
(AFD), respectively.  
 
As first author of this paper, I collected, analysed and interpreted the data and drafted and edited the 
manuscript. My co-authors Stephen Rose, Kerstin Pannek, James Doecke and Lee Reid contributed 
to the computational analysis and interpretation of results. My co-authors Kate Sinclair, Simona Fiori 
and Martin Lavin contributed to the clinical interpretation of results. All co-authors provided critical 
revision of the article. 
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Abstract 
Our understanding of the effect of ataxia-telangiectasia mutated gene mutations on brain structure 
and function is limited. In this study, white matter motor pathway integrity was investigated in ataxia-
telangiectasia patients using diffusion MRI and probabilistic tractography. Diffusion MRI were 
obtained from 12 patients (age range: 7-22 years, mean: 12 years) and 12 typically developing age-
matched participants (age range 8-23 years, mean: 13 years). White matter fibre tracking and whole 
tract statistical analyses were used to assess quantitative fractional anisotropy and mean diffusivity 
differences along the cortico-ponto-cerebellar, cerebellar-thalamo-cortical, somatosensory and lateral 
corticospinal tract length in patients using a linear mixed effects model. White matter tract streamline 
number and apparent fibre density in patient and control tracts were also assessed. Reduced fractional 
anisotropy along all analysed patient tracts were observed (p<0.001). Mean diffusivity was 
significantly elevated in anterior tract locations but was reduced within cerebellar peduncle regions 
of all patient tracts (p<0.001). Reduced tract streamline number and tract volume in the left and right 
corticospinal and somatosensory tracts were observed in patients (p<0.006). In addition, reduced 
apparent fibre density in the left and right corticospinal and right somatosensory tracts (p<0.006) 
occurred in patients. Whole tract analysis of the corticomotor, corticospinal and somatosensory 
pathways in ataxia-telangiectasia showed significant white matter degeneration along the entire 
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length of motor circuits, highlighting that ataxia-telangiectasia gene mutation impacts the cerebellum 
and multiple other motor circuits in young patients. 
 
Introduction 
The autosomal recessive neurodegenerative disorder ataxia-telangiectasia (A-T) occurs in 
approximately 3 per million live births.1 ATM (ataxia-telangiectasia mutated) gene mutations give 
rise to this multisystem disorder2, 3 which is characterised by progressive cerebellar ataxia, 
immunodeficiency, sinopulmonary infections, oculocutaneous telangiectasia 4, 5 and elevated serum 
alpha-fetoprotein levels.6 The protein kinase ATM, a key player in the cellular response to DNA 
damage is activated by DNA double-stranded breaks.7, 8 The ATM protein is also involved in the 
response to oxidative damage, being activated by oxidative stress9 and may have a more general role 
in cell homeostasis. Activated ATM phosphorylates a multitude of proteins controlling various 
cellular processes, specifically cell cycle checkpoint pathways10 and DNA repair.8 ATM gene 
mutations are linked to increased radiosensitivity both in A-T patients11, 12 and in patient cells in 
culture.13, 14 The cause of death in most A-T patients is lymphoreticular malignancy or recurrent 
chronic respiratory infections.4, 5 
 
To date, conventional T1- and T2-weighted MRI imaging studies have highlighted hallmark 
neuropathological features, namely progressive cerebellar atrophy, in A-T (reviewed in Sahama15). 
From a radiological perspective this has been useful, however such studies provide limited insight 
into neurodegeneration and its association with loss of connectivity in multiple neural networks. 
Recently, we reported volume reductions in cortical motor regions in children with A-T using voxel-
based morphometry (VBM) applied to structural MRI data.183 Furthermore we observed WM 
structural changes within the cerebellum, cerebellar peduncles and in motor regions traversing the 
posterior limb of the internal capsule using diffusion MRI (dMRI) and tract-based spatial statistics 
(TBSS).183 In this approach, diffusion tensor imaging (DTI) was used to measure the preferred 
direction of water diffusion along WM fibre tracts.18 DTI provides quantitative measures of diffusion 
anisotropy, such as fractional anisotropy (FA), which is thought to reflect axonal WM fibre 
degeneration.37, 160, 161 Mean diffusivity (MD), a quantitative measure of the mean motion of water 
considered in all directions, can be used to interrogate pathological cerebral tissue changes, such as 
demyelination.57 Typically, decreases in FA, and increases in MD reflect WM fibre degeneration 
(reviewed in Beaulieu37).  
 
Although voxel-wise analyses of FA and MD in A-T patients identify altered WM integrity,183 a 
limitation of this approach is that it does not provide information about specific WM pathways 
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affected by neurodegenerative changes. When DTI is used in conjunction with probabilistic 
tractography algorithms, probabilistic maps of specific fibre tracts can be generated, enabling the 
connectivity of pathways linking multiple brain regions to be interrogated. 160, 161  
 
DTI and fibre tracking have been applied to study cerebellar - corticomotor networks in a number of 
ataxic conditions21-28 other than A-T. Although histopathological evidence for collective atrophy in 
pontocerebellar pathways,87 altered evoked potentials and myelinated fibre loss in spinal cord sensory 
pathways,4, 88, 93, 94, 97, 184, 185 and demyelination of corticospinal tracts (CST) have been reported in A-
T,87, 89 these findings relate to post-mortem studies, usually at the end stages of disease. dMRI studies 
that employ probabilistic tractography to analyse WM pathway integrity and connectivity to multiple 
brain regions is urgently required to fully understand the impact of the ATM gene mutation on A-T 
motor circuits.  
 
To this end, the present study employed the use of an ‘along tract’ statistical approach,65 whereby 
diffusion imaging metrics (FA and MD) were measured along the length of lateral CST, 
somatosensory, cortico-ponto-cerebellar (CPC) and cerebellar-thalamo-cortical (CTC) tracts in 
young A-T and typically developing age-matched participants. Compared to standard ‘tract-
averaged’ tractography, which provides one averaged FA and MD value per tract (reviewed in 
Colby65), the along tract protocol calculates FA and MD values at consistent intervals along the entire 
tract length, thereby providing a comprehensive view of the anatomical variation in WM integrity 
along neural pathways. 
 
In addition to whole tract analysis, A-T WM tract streamline count, tract volume and apparent fibre 
density (AFD) were analysed in this study. Tract streamline counts can be used to detect general 
degeneration of A-T tracts. Tract volume measures the total voxel volume of all voxels belonging to 
the tract pathway of interest and when normalised to the intracranial volume (ICV), can provide an 
informed insight into hemisphere-specific WM changes.186 Similarly, AFD, a tract specific measure 
derived from the fibre orientation distribution (FOD), allows identification of structural differences 
along single fibre bundles and assessment of connectivity between two anatomical regions that 
encompass a specific tract.66 Using whole tract analysis, WM tract streamline count, tract volume and 
AFD measures, we present novel findings depicting loss in WM integrity along the entire tract length 
of CPC, CTC, somatosensory and CST pathways in A-T. 
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Methods 
Participants 
MRI data were acquired from 12 patients with A-T (age mean SD: 12±5.34; age range: 7-22 years, 6 
Males) and 12 healthy, age-matched typically developing participants (age mean SD: 12.67±5.28; 
age range 8-23 years, 4 Males). All patients have been clinically diagnosed with A-T, according to 
the recent World Health Organisation recommendations166 including genetic testing. Informed 
consent was given by all subjects and parents in accordance with our Human Ethics Institutional 
Review Board and the Declaration of Helsinki. 
 
Clinical scoring 
The A-T Neuro Examination Scale Toolkit (A-T NEST), which was refined from a quantitative 10-
point scale,167 was used to clinically observe A-T patients. This scaling system is a sensitive tool that 
specifically accounts for the multi-dimensional complexity and heterogeneity of A-T neurological 
deficits (personal communication with Dr. Thomas Crawford, Professor of Neurology and Paediatrics 
at the John Hopkins Hospital). 
 
Image acquisition  
MRI data were acquired using a 3T MRI scanner (Siemens Trio, Erlangen, Germany) with TQ 
gradients (45 mT/m, slew rate 200 T/m/s), using a 12-element Tim head array. A 0.9 mm isotropic 
3D T1 Magnetisation Prepared Rapid Gradient Echo (MPRAGE) sequence was used to acquire a 
high-resolution structural image. The imaging parameters were: field of view 23×23×17.3 cm; 
TR/TE/TI 1900/2.32/900 ms; flip angle 9o; and matrix size 192×512×512×1 cm. Diffusion MRI 
acquisition consisted of a High Angular Resolution Diffusion Imaging (HARDI) sequence with the 
following parameters: 60 axial slices; 2.5 mm slice thickness; field of view 30×30 cm; TR/TE 
9500/116 ms; and acquisition matrix 128×128, resulting in an in-plane resolution of 2.34×2.34 mm. 
To reduce susceptibility distortions, parallel imaging with an acceleration factor of 2 was employed. 
Sixty-four diffusion-weighted images were acquired at b = 3,000 s mm-2, along with one minimally 
diffusion-weighted image (b = 0). The acquisition time for the diffusion dataset was 9:40 minutes. 
Two 2-dimensional gradient-recalled echo images (36 axial slices; 3 mm slice thickness with 0.75 
mm gap; field of view 19.2×19.2 cm; TR/TE1/TE2 488/4.92/7.38 ms; acquisition matrix 64×64) were 
used to acquire a field map for diffusion data, to assist distortion correction due to susceptibility 
inhomogeneity.  
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Diffusion processing 
Diffusion-weighted images were corrected for subject motion by identifying head movement within 
volumes using the discontinuity index and subsequently using the Fit Model to All Measurements 
(FMAM) method to correct movement between volumes.172 Susceptibility distortions were corrected 
using the field map employing FMRIB's Utility for Geometrically Unwarping EPIs (FUGUE)187 and 
Phase Region Expanding Labeller for Unwrapping Discrete Estimates (PRELUDE)188 in raw image 
space (both contained within FMRIB’s Software Library (FSL)),169 with signal intensity 
correction.189 Motion artefacts were identified and replaced using Detection and Replacement of 
Outliers Prior to Resampling (DROP-R),171 modified from the originally proposed method to 
incorporate an outlier detection technique suitable for high b-value diffusion data.175 Using the 
corrected data, the fibre orientation distribution (FOD) was estimated using the constrained spherical 
deconvolution (CSD) method within the MRtrix package (https://github.com/jdtournier/mrtrix3).58 
MRtrix was also used to generate FA and MD maps.  
 
Tractography 
Probabilistic tractography was performed using MRtrix3. To extract WM fibre tracks of interest, 
anatomically constrained tractography (ACT)63 was performed. T1 co-registration to the diffusion 
imaging series, and subsequent FSL BET/FAST/FIRST processing on structural data as per the 
MRtrix3 ‘act_anat_prepare_fsl’ script were conducted to produce a ‘five tissue types’ mask, to 
generate whole brain tractograms comprising fifty million streamlines.59 Whole brain tractograms 
were subsequently processed using the Spherical-deconvolution Informed Filtering of Tractograms 
(SIFT) procedure introduced in MRtrix3, resulting in twenty-five million streamlines,64 to reduce 
false positive streamlines. The MRtrix package was used to select regions-of-interest (ROIs) to enable 
extraction of the CPC, CTC, CST and somatosensory fibre tracks from SIFTed whole brain 
tractograms. ROIs, particularly for the CST and somatosensory tracts, were identified using 
established target regions specific to children190, 191 and verified manually by an expert child 
neurologist (SF). Reliability of ROI placement within and between subjects was determined by 
manual selection of ROIs for each subject, followed by careful expert cross-checking of ROI accuracy 
and placement. ROIs were placed in the precentral and postcentral gyri and spinal cord for CST, 
postcentral gyrus and spinal cord for the somatosensory tracts and cerebral hemispheres and opposing 
medial cerebellar peduncle and superior cerebellar peduncle regions for the CPC and CTC tracts, 
respectively (Figure 4.1).  
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Figure 4.1. Region of Interest (ROI) placement for representative somatosensory motor cortex tracts 
for a control participant (age 23): Corticospinal (CST), somatosensory (Somato), cortico-ponto-
cerebellar (CPC) and cerebellar-thalamo-cortical (CTC) tract ROIs in the cerebral cortex (first row) 
and cerebellar peduncles (second row). Colouration is based on the direction of water diffusion (Blue: 
ascending-descending diffusion; Red: left-right diffusion; Green: anterior-posterior diffusion). 
 
Along Tract Statistical analysis 
Quantitative tractography metrics (FA and MD) were derived using whole tract methodology. Motor 
circuits were defined according to ‘start’ and ‘end’ ROIs (visualised in Figure 4.1 first and second 
rows respectively) and cropped at ‘end’ ROIs to ensure similar tract length of all tracts within the 
circuit. Further removal of spurious tracts was achieved by rejecting 10% of the longest tracts in 
motor circuits. FA and MD were sampled by automated segmentation of individual tracts into 20 
locations (bins) of equal streamline point count to ensure minimal data variance in metrics along the 
tract. This approach ensures anatomically coincident bins to be sampled along each tract of interest 
for each participant. FA and MD values within one patient were statistically compared to a 
corresponding age-matched control at each bin along each tract, using a linear mixed effects model. 
Bin location along the tract was associated with an anatomical landmark in individual patients to 
pinpoint WM changes by brain region in A-T. P-values less than or equal to 0.001 were considered 
statistically significant after p-value alpha adjustment for 40 multiple tests of hypotheses based on 
bin number (20) and condition (control or patient (2)) per bin, equating to the evaluation of individual 
bins in each subject group. In addition, MD values in all control and patient ROIs at the level of the 
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cerebral motor cortex (parietal cortex) and the cerebellar peduncles were computed using the ‘fslstats’ 
command, part of FSL169 to cross-check MD values in selected corticomotor pathways. P-values less 
than or equal to 0.005 were considered statistically significant for this analysis after p-value alpha 
adjustment for 11 multiple tests of hypotheses, corresponding to the total number of ROIs selected. 
All statistical analyses and data visualisation were performed using the R statistical environment.192 
 
WM Tract Streamline Number, Tract Volume and AFD Statistical analysis 
As tensor based diffusivity measures are voxel-average quantities and not tract specific in voxels 
containing complex fibre architecture, streamline number, tract volume and AFD metrics were also 
investigated in this study. Streamline number, tract volume and AFD in A-T and control participants 
were calculated and averaged based on patient or control condition per tract due to the small number 
of subjects undergoing analysis. Tract volume was derived using the ‘fslstats’ command, part of 
FSL169 and normalised based on ICV.186 At high diffusion gradient b-values, the AFD is proportional 
to the intra-axonal volume of axons associated with that FOD lobe.66 Summing the AFD integral for 
all FOD lobes associated with the tract streamlines enables generation of a measure related to the 
total intra-axonal tract volume. The AFD integral is normalised by dividing by the mean streamline 
length to yield a measure proportional to tract cross sectional area, and can be used to compare tract 
specific degeneration in A-T participants and age-matched control participants. AFD values 
(corrected and uncorrected for partial volume effects) were calculated using the ‘afdconnectivity’ 
command in MRtrix3 (https://github.com/jdtournier/mrtrix3). Parametric test assumptions of 
homogeneity of variance and normal distribution were assessed and confirmed prior to all statistical 
analyses. Statistical differences in streamline number, tract volume and AFD between patient and 
control conditions were computed using an independent t-test and visualised using the R statistical 
environment.192 Streamline number, tract volume and AFD measures were considered significant 
after p-value alpha adjustment for 8 multiple tests of hypotheses based on number of tracts analysed 
(p<0.006).  
 
Results 
Clinical observations  
Heterogenous ataxia and movement disorder were observed in A-T patients, irrespective of age. 
Clinical scores in four young patients depicted advanced WM degeneration, with variations in ataxic 
mobility (walking and standing) and neuropathy, the absence of ankle, knee and bicep tendon reflexes 
and loss of proprioception in the extremities (Patients 2, 7, 9 and 11, (7-10) years of age, Table 4.1, 
Appendices).  
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Whole Tract Analysis of Control and Patient WM Tracts 
Lateral CST, CPC, CTC and somatosensory tracts descend from the cerebral motor cortex at the level 
of the parietal lobe to the cerebellar peduncles collectively, connecting these two regions. Compared 
to motor pathways in age-matched controls, A-T CST and somatosensory pathways display a 
morphological thinning of tracts at the level of the thalamus in the coronal view. In addition, A-T 
CPC and CTC pathways display morphological thinning of tracts in the cerebellum at the position of 
the medial cerebellar peduncles (Figure 4.2). 
 
Figure 4.2. Somatosensory motor tracts in a representative control and ataxia-telangiectasia (A-T) 
subject (age 23): Control tracts are displayed in the first and second rows comprising the left sagittal 
(first row) tracts, left and right coronal (second row) corticospinal (CST) and somatosensory tracts, 
and left coronal (second row) cortico-ponto-cerebellar (CPC) and cerebellar-thalamo-cortical (CTC) 
tracts. Patient tracts are displayed in the third and fourth rows comprising the left sagittal (third row) 
tracts, left and right coronal (fourth row) CST and somatosensory tracts, and left coronal (fourth row) 
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CPC and CTC tracts. Colouration of tracts is based on the direction of water diffusion (Blue: 
ascending-descending diffusion; Red: left-right diffusion; Green: anterior-posterior diffusion). 
 
Significant FA reductions along the lateral CST, CPC, CTC and somatosensory tracts were observed 
collectively in A-T patients compared to controls (p<0.001, Figure 4.3, for all tracts). Areas of non-
significant FA changes in the left CTC at 5%, 11% and 32% of the tract length and in the right CTC 
at 0% and 5% of the tract length were observed in A-T (Figure 4.3, denoted by ‘N’). A general 
decrease in average FA magnitude (approximated to two decimal places and averaged across age) 
between control and patient groups was observed along all analysed corticomotor tracts (Table 4.2, 
Appendices).  
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Figure 4.3. Smooth estimates of the average fractional anisotropy (FA) of all controls (blue) and 
patients (red) are plotted versus position from tract origin (cerebral motor cortex (0%) – cerebellar 
peduncles (100%)), faceted by tract name (Corticospinal (CST), somatosensory (Somato), Cortico-
ponto-cerebellar (CPC), Cerebellar-thalamo-cortical (CTC)) and hemisphere (Left (L.) and Right (R.) 
± pointwise 99% confidence range (light grey shading)). Tract position at 0-5% represents precentral 
and postcentral gyrus layers, at 47-58% represents thalamic layers in all tracts and at 95-100% 
represents the spinal cord in CST and somatosensory tracts, and position of the medial cerebellar and 
superior cerebellar peduncles connecting the brainstem and cerebellum for the CPC and CTC tracts, 
respectively. ‘N’ denotes tract locations with non-significant values. 
 
A significant increase in MD in all A-T WM pathways was recorded at the level of the cerebral cortex 
(0%-50% of tract length), however, a paradoxical decrease in MD was observed at the level of the 
cerebellar peduncles (50%-100% of tract length) in all tracts (p<0.001, Figure 4.4). To cross-check 
the decrease in MD, a cross-examination of ROIs at the cerebral (precentral and postcentral gyrus) 
and cerebellar peduncle levels in patients and controls was conducted and revealed neither an increase 
nor decrease in MD at the cerebral and cerebellar levels in these ROIs respectively, in patients (data 
not shown). In addition, static change in average MD magnitude (approximated to two decimal places 
and averaged across age) between the control and patient groups was observed along all analysed 
corticomotor tracts (Table 4.2, Appendices). Areas of non-significant MD change in the right CPC 
tract at 32% of the tract length and in the right CTC tract at 0% and 37% of the tract length were 
observed in patients (Figure 4.4, denoted by ‘N’).  
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Figure 4.4. Smooth estimates of the average mean diffusivity (MD) of all controls (blue) and patients 
(red) are plotted versus position from tract origin (cerebral motor cortex (0%) – cerebellar peduncles 
(100%)), faceted by tract name (Corticospinal (CST), somatosensory (Somato), Cortico-ponto-
cerebellar (CPC), Cerebellar-thalamo-cortical (CTC)) and hemisphere (Left (L.) and Right (R.) ± 
pointwise 99% confidence range (light grey shading)). Tract position at 0-5% represents precentral 
and postcentral gyrus layers, at 47-58% represents thalamic layers in all tracts and at 95-100% 
represents the spinal cord in CST and somatosensory tracts, and position of the medial cerebellar and 
superior cerebellar peduncles connecting the brainstem and cerebellum for the CPC and CTC tracts, 
respectively. ‘N’ denotes tract locations with non-significant values. 
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Streamline Number and Tract Volume Analysis 
Reduced streamline number in the left and right CST and right somatosensory tracts was observed in 
A-T patients (p<0.006, Figure 4.5A). Tract volume reductions were observed in the left CTC, left 
somatosensory, right CPC and right CST A-T tracts (p<0.006, Figure 4.5C).  
 
Figure 4.5. Number of white matter (WM) streamlines, tract volume and apparent fibre density 
(AFD) in control and patient tracts: A) Mean number of streamlines in WM tracts (Corticospinal 
(CST), somatosensory (Somato), Cortico-ponto-cerebellar (CPC), Cerebellar-thalamo-cortical 
(CTC)) (Left (L.) and Right (R.) ± pointwise 95% confidence interval) is plotted with significance 
(*, p<0.006). B) The mean AFD in WM tracts (Left (L.) and Right (R.) ± pointwise 95% confidence 
interval) is plotted with significance (*, p<0.006). C) The mean tract volume (mL) in WM tracts (Left 
(L.) and Right (R.) ± pointwise 95% confidence interval) is plotted with significance (*, p<0.006). 
D) The mean AFD in WM tracts (Left (L.) and Right (R.) ± pointwise 95% confidence interval) 
corrected for partial volume effects is plotted with significance (*, p<0.006). 
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AFD Analysis 
Reductions in fibre integrity in the right CST and somatosensory tracts in A-T subjects were observed 
compared to controls (p<0.006, Figure 4.5B). Reductions in fibre integrity in the left and right CST 
and right somatosensory tracts in A-T subjects were also observed when corrected for partial volume 
effects (p<0.006, Figure 4.5D). Although not reaching a level of significance, the left CST (Figure 
4.5B), left somatosensory and right CPC tracts (Figure 4.5B and D) displayed a trend towards reduced 
integrity in A-T subjects. Higher AFD was found in the right CTC tracts in A-T (p<0.006, Figure 
4.5B), however this result was not significant in partial volume corrected data (Figure 4.5D), 
suggesting the influence of small streamline numbers delineating in this pathway.  
 
Discussion  
dMRI and probabilistic tractography have not yet been applied to A-T despite its use in investigating 
cerebellar WM degeneration in multi-spectrum ataxic disorders.22, 25, 28 In this study, WM 
microstructural analysis of cerebellar-corticomotor and corticospinal pathways was conducted in a 
sizeable A-T cohort using an appropriate analysis pipeline. Specifically, anatomical variation in WM 
integrity along motor tract length was demonstrated for the first time in A-T.  
 
Neurodegeneration of the lateral CST, CPC, CTC and somatosensory tracts along tract length was 
collectively observed among all A-T patients in this study. Analysis of FA and MD differences along 
the whole tract resulted in p-values with a magnitude of less than or equal to 10-6 (data not shown), 
indicating significant neurodegenerative change among A-T corticomotor and corticospinal tracts 
compared to age-matched control participants. FA reductions in the cerebral cortex, cerebellar and 
spinal cord regions suggest involvement of these areas in young A-T patients, and provide an insight 
into the advanced state of neuropathy, absence of reflexes (ankle, knee and bicep tendons) and 
proprioception observed in the extremities of these patients. While cerebellar degeneration is a well-
established finding in A-T, structural changes in the cerebral motor cortex and spinal cord, 
particularly in histopathological studies, have been confined mainly to older A-T patients (reviewed 
in Sahama15) and sparingly in young patients.88, 157 Cerebral abnormalities in structural MRI studies 
have also been observed largely in adult A-T patients,145, 158, 193 however exceptional cases in early 
A-T have been noted.157 Our current findings of cerebellar, somatosensory and spinal cord 
neurodegeneration, and our previous observations of reduced grey matter density in A-T motor 
regions,183 provide evidence that the thalamus, precentral gyrus and postcentral gyrus are likely 
affected in our young A-T patient cohort. To our knowledge, involvement of these cortical areas has 
not previously been reported in imaging studies in A-T, however reduced metabolism in the fusiform 
gyrus of the cerebral cortex has been observed using 18F-FDG PET imaging.194 
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In contrast to MD findings in neurodegenerative conditions (reviewed in Beaulieu37), a marked 
decrease in MD at the cerebellar peduncles was observed for all A-T tracts in this study, despite the 
lack of MD differences at the cerebral and cerebellar ROIs in patients and controls (data not shown), 
and the static change in average MD magnitude across patient age in corticomotor pathways. MD 
reductions have previously been reported during the hyperacute stages of ischemic stroke. In stroke, 
MD reduction has been postulated to be caused by cell swelling, where post ischemic energy failure 
causes sodium (Na+), potassium (K+)-ATPase transmembrane pump failure, inducing loss of ion 
homeostasis, excitatory amino acid release and water influx from extracellular to intracellular cell 
space (reviewed in Jones195). Such marked changes in ion homeostasis are unlikely to occur in A-T, 
since A-T neurons differentiated from induced pluripotent stem cells display similar voltage-gated 
potassium and sodium currents and action potential discharge as healthy neurons. Nevertheless, 
defective neuronal growth associated protein and potassium channel-interacting protein expression 
was observed in that study.196 In a recent study, neural progenitors differentiated from olfactory 
neurosphere-derived cells in A-T patients were defective in neurite formation, neurite number and 
length.197 In addition, a mouse model of A-T displayed decreases in the duration of calcium and 
sodium firing in Purkinje cells, with the presence of progressive calcium deficit despite normal resting 
membrane potential, input resistance or anomalous rectification (potassium currents) in cells. 
Calcium deficits were caused by decreases in calcium currents and were related to cell death in other 
tested mutant mice.198 While these findings do not provide evidence for an imbalance in ion 
homeostasis in A-T neurons, they nevertheless indicate A-T neuronal cell abnormalities which could 
fit with MD reduction in the A-T cerebellum and spinal cord in the current study. MD reductions in 
A-T may also be markers of neurodegeneration, as restricted and hindered diffusion have been 
reported to decrease the apparent diffusivity of water,199, 200 particularly where acute Wallerian 
degeneration is involved.201 Currently, it is unclear whether neurodegeneration in A-T involves 
Wallerian degeneration in associated corticomotor pathways. Future use of longitudinal studies to 
track neurodegeneration in patients from early age to chronic disease states may allow the 
clarification of such degenerative involvement. Nevertheless, cell death in cerebellar regions is 
prevalent in A-T and are correlated with MD reductions, as are astrocyte reactivity and 
microglial/macrophage activation within the cerebral cortex.200 Therefore MD reductions in this study 
may also reflect chronic oxidative stress-induced Purkinje cell death, thought to be the primary cause 
of neurodegeneration, as a consequence of failure to actively regulate oxidative stress levels in the A-
T cerebellum (reviewed in Sahama15). Overall, the unpredictable combination of demyelination, axon 
loss, gliosis, and inflammation in individual A-T patients may result in competing influences of 
quantitative DTI metrics in brain regions. To improve DTI metric specificity in A-T, a combination 
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of multiple imaging measures (e.g., T1, T2, magnetisation transfer, perfusion, fast/slow diffusion)57 
is required.  
 
Reductions in WM tract streamline number, tract volume and AFD measures coincided with FA 
reduction in robust WM tracts, in particular, in the left and right CST and somatosensory tracts in A-
T. AFD connectivity and streamline number are highly related to one another when ACT and SIFT 
protocols are used, however, the localisation of neurodegenerative changes to the right hemisphere in 
A-T is unprecedented. Previously, we reported significant cerebellar-corticomotor pathway changes 
localised to only the left cerebral hemisphere in A-T using a different analysis technique, namely 
TBSS,42, 44 with no clear correlation to clinical observations.183 TBSS is a voxel-wise analysis 
technique that is less specific to probing the integrity of individual WM pathways. Although we 
reported only significant changes in FA and MD within left hemispheric WM pathways, we did 
observe similar changes within corresponding right hemisphere WM (uncorrected) that did not reach 
a level of statistical significance. The observation of both left and right hemisphere WM motor tract 
involvement in the current analysis may indicate the added sensitivity of the more specific along tract 
analysis approach. In structural imaging, there is little evidence of right cerebral laterality in A-T, 
particularly in the present A-T cohort (data not shown), however, post-mortem studies have recorded 
lesions exclusive to the right thalamus88 and right temporal WM.91 Localised WM maturation in the 
control population may also contribute to the laterality observed in streamline number and AFD 
metrics in our A-T patients. Indeed, voxel-wise analysis and DTI imaging in healthy children and 
adults have revealed increased FA and decreased MD with increasing age in the right temporal lobe202 
and right inferior longitudinal fasciculus.203 These observations however, are cohort specific, thus 
WM tract streamline number and AFD laterality in this study may also be specific to our patient 
cohort.  
 
Low streamline numbers in control and A-T CPC and CTC tracts highlight the challenge of robustly 
defining these pathways using dMRI acquisition schemes suitable for clinical populations (less than 
10 minute scan time). Given this limitation, some caution needs to be observed when deferring 
information about degeneration processes occurring within these pathways. It should be noted that 
only streamlines hitting both cerebellar and cortical targets were included in this study. Many 
streamlines projecting from the cerebellum failed to project into the motor cortex and therefore has 
the potential for biasing streamline number analyses. Clearly, larger cohorts are needed to better 
define integrity of these motor pathways.  
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The primary limitation of this study is the small A-T cohort that underwent analysis and impacted on 
the findings. Fewer than 50 A-T cases have been reported in Australia overall,181 with this study’s 
clinical population recruited from the only research clinic nationally, specialising in health care for 
an estimated 54% of the national A-T population. In addition, the use of non-sedated MRI scanning 
in this study has restricted the age range of patients to age 6 and above. To understand the extent of 
multiple affected brain areas and their sequence of development in early and advanced A-T, larger 
collaborative studies across multiple research sites182 are required. Another significant limitation is 
the inability of dMRI to accurately resolve crossing fibre tracts in complex WM architecture.54 
Specifically, multiple fibres that cross within each voxel provide unintuitive quantitative DTI 
measures. Indeed, in neurodegenerative conditions, increased anisotropy can be observed in regions 
of crossing fibres,55 and is observed in average FA magnitude values per bin in the present study. In 
the cases of Wallerian degeneration, almost no change in diffusion anisotropy can be detected where 
degenerated pathways cross other tracts.56 The use of a higher order model can resolve multiple 
crossing fibres within each voxel58 and can improve the accuracy of tract delineations with 
tractography however, paradoxical changes in FA and MD (calculated using the diffusion tensor 
model), as seen in the measure of A-T WM integrity in the present study, can confound interpretation 
of results. Multiple imaging metrics in combination with higher order models allow complex 
neurodegenerative processes in A-T to be interpreted comprehensively thus streamline number, tract 
volume and AFD measures were introduced in this study to obtain a broader understanding of the 
neurological processes that contribute to A-T neurodegeneration.  
 
In future, investigation of the cerebro-olivocerebellar and cerebro-reticular cerebellar pathways is 
required in A-T due to involvement of the inferior olives87-90, 94 and the medullary reticular 
formation88 in the disease. The dorsal spinocerebellar tracts in A-T88, 95 also warrant further 
investigation but were excluded in the current study due to insufficient tract length in brain MRI for 
whole tract analysis. In future, spinal cord MRI could be employed to effectively capture these tracts 
in their entirety for analysis. 
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CHAPTER 5 
 
Serial investigation of neurodegeneration 
in young ataxia-telangiectasia patients 
 
This chapter includes the fourth manuscript produced during PhD candidature, which was submitted 
for review to Paediatric Neurology in 2015. The report details a longitudinal dMRI study of A-T 
imaging data acquired over the three year course of this project. This study addresses the third aim of 
the project, to ‘investigate if A-T neuropathy is localised to the cerebellum or extends to the entire 
motor cortex in serial study of patients’.  
 
The paper highlights the use of a sensitive TBSS and VBM procedure to quantitatively assess whole 
brain WM integrity (FA and MD) and GM volume between A-T T1 and dMRI data sets between 
years one and two, one and three and two and three in patients, respectively. The paper also highlights 
serial volumetric analysis of the basal ganglia, thalamus and cerebellum and serial ROI analysis of 
the medial cerebellar peduncle (MCP) and posterior limb of the internal capsule (PLIC), that represent 
areas of corticomotor and corticospinal pathway degeneration in A-T patients, respectively (Chapter 
3). Overall, this paper attempts to provide a complete picture of the neurodegenerative progression in 
A-T patients over two years of study, an outcome that has not been attempted before using diffusion 
MRI. 
 
As first author of this paper, I collected, analysed and interpreted the data and drafted and edited the 
manuscript. My co-author Jurgen Fripp contributed to the data processing. My co-authors Stephen 
Rose and Kerstin Pannek contributed to the interpretation of results. My co-authors Kate Sinclair and 
Martin Lavin contributed to the clinical interpretation of results. All co-authors critically revised the 
article. 
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Abstract 
Although progressive ataxia and oculomotor apraxia are well-recognised clinical features of ataxia-
telangiectasia, very little is known about neurodegenerative changes over time within key brain 
structures known to be associated with motor function and control in this disease. To investigate these 
changes, serial structural and diffusion-weighted MRI data were acquired from 10 ataxia-
telangiectasia patients (4 male: age range: 6-16 years). Corticomotor white matter microstructure and 
volumetric change of the caudate, putamen, thalamus, and cerebellum were quantitatively measured 
over a period of two years. Despite progressive loss of motor function in some participants (3/10 
patients), based on a group-wise paired t-test analysis, we found no significant white matter 
microscopic or volumetric changes within these brain regions. This finding highlights that within a 
cohort of young patients with well-established patterns of cerebellar atrophy on MRI at baseline, 
progressive degeneration of thalamic, cerebellar, basal ganglia regions as well as corticomotor 
cerebellar white matter microstructural changes occur at a surprisingly slow rate. This finding has 
implications for our understanding of early neurodegenerative change and potential benefit of the use 
of neuroprotective or neural-restorative therapies for ataxia-telangiectasia. 
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Introduction 
Ataxia-telangiectasia (A-T) is a neurodegenerative disorder marked by progressive cerebellar ataxia, 
immunodeficiency, sinopulmonary infections, oculocutaneous telangiectasia4, 5 and elevated serum 
alpha-fetoprotein levels.6 The multi-system characteristics of this autosomal recessive condition are 
caused by the ATM (ataxia-telangiectasia mutated) gene mutations.2, 3 Recurrent chronic respiratory 
infections and lung complications resulting therefrom, as well as lymphoid malignancy4, 5 are the 
causes of death in A-T.  
 
To date, imaging studies in A-T have involved T1- and T2-weighted structural imaging that are useful 
from a radiological perspective, but provide limited insight into neurodegeneration and loss of 
multiple neural network connectivity in A-T. A-T neurodegeneration can be probed using appropriate 
analysis pipelines. Recently, we have shown that diffusion and structural MRI uncovers grey matter 
(GM) volume reductions in cortical motor regions and white matter (WM) structural changes in the 
cerebellum, anterior/posterior horns of the medulla, cerebral peduncles and posterior limb of the 
internal capsule (PLIC) in children with A-T compared to age-matched typically developing 
children.183 Diffusion tensor imaging (DTI) in this analysis enabled the quantification of the preferred 
diffusion direction (diffusion anisotropy) of water along WM fibre tracts,18 using fractional 
anisotropy (FA) and mean diffusivity (MD) measures, the former of which is thought to reflect axonal 
WM fibre degeneration,37, 160, 161 and the latter of which measures mean water motion in all 
directions.57 Decreases in FA and increases in MD reflect WM fibre degeneration (reviewed in 
Beaulieu37) and together, infer pathological changes in cerebral tissue, such as demyelination.57 
 
Although progressive loss of motor function is well recognised in A-T, there is limited information 
about volumetric and WM microstructural changes to key brain structures known to be associated 
with motor function and control from an imaging perspective. To improve our understanding of the 
patterns of neurodegenerative change in A-T patients over time, we employ a series of voxel-wise 
and region-of-interest (ROI) analyses of diffusion MRI (dMRI) data to track WM integrity of key 
corticospinal and corticomotor cerebellar pathways in this study. In addition, volumetric analysis of 
cerebellar, and a number of subcortical brain regions (caudate, putamen and thalamus) are 
quantitatively assessed over a two year period using structural MRI. Overall, this study probes the 
pattern and magnitude of GM and WM neurodegenerative trajectories, which are important 
considerations for future development and application of neuroprotective or neural-restorative 
therapies in A-T. 
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Methods 
Participants 
MRI data were acquired once per year over two years from 10 A-T patients (4 male: age range: 6-16 
years). Five patients did not provide data in year 2 (time point 3) of this study. All patients were 
clinically diagnosed with human A-T in accordance with the recent World Health Organisation 
recommendations166 including genetic testing. All parents of young patients gave informed consent 
as per the Human Ethics Institutional Review Board and the Declaration of Helsinki.  
 
Clinical assessment 
Neurological deficits were quantitatively assessed using the A-T Neuro Examination Scale Toolkit 
(A-T NEST).167 The A-T NEST accounts for the multi-dimensional nature of A-T characteristics and 
compensates for the disease’s complexity and heterogeneity, making for an effective and sensitive 
method to precisely measure A-T neurological deficits. 
 
Image acquisition  
A 3T MRI scanner (Siemens Trio, Erlangen, Germany) with TQ gradients (45 mT/m, slew rate 200 
T/m/s) and 12-element Tim head array was used to acquire MRI images. High-resolution structural 
images were acquired using a 0.9 mm isotropic 3D T1 Magnetisation Prepared Rapid Gradient Echo 
(MPRAGE) sequence. T2-weighted structural images were acquired for radiological assessment 
using the T2 Half Fourier Acquisition Single Shot Turbo Spin Echo (HASTE) sequence. The imaging 
parameters were: field of view 23×23×17.3 cm; TR/TE/TI 1900/2.32/900 ms; flip angle 9o; matrix 
size 192×512×512×1 cm. The following parameters in the High Angular Resolution Diffusion 
Imaging (HARDI) sequence were used to acquire diffusion images: 60 axial slices; 2.5 mm slice 
thickness; field of view 30×30 cm; TR/TE 9500/116 ms; acquisition matrix 128×128, resulting in an 
in-plane resolution of 2.34×2.34 mm. Susceptibility distortions were reduced by employing an 
acceleration factor of 2 to parallel imaging. Sixty-four diffusion-weighted images were acquired at b 
= 3,000 s mm-2, along with one minimally diffusion-weighted image (b = 0). The diffusion dataset 
acquisition time was 9:40 minutes. A field map for diffusion data, using two 2-dimensional gradient-
recalled echo images (36 axial slices; 3 mm slice thickness with 0.75 mm gap; field of view 19.2×19.2 
cm; TR/TE1/TE2 488/4.92/7.38 ms; acquisition matrix 64×64) was used to correct for distortions due 
to susceptibility inhomogeneity. 
 
Diffusion processing  
Head movement within diffusion-weighted image volumes were identified using the discontinuity 
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index168 and movement between volumes was corrected using the Fit Model to All Measurements 
(FMAM) method.172 FMRIB's Utility for Geometrically Unwarping EPIs (FUGUE)187 and Phase 
Region Expanding Labeller for Unwrapping Discrete Estimates (PRELUDE)188 (both contained 
within FMRIB’s Software Library (FSL))169 were employed in raw image space, with signal intensity 
correction189 to correct for susceptibility distortions using the field map. The Detection and 
Replacement of Outliers Prior to Resampling (DROP-R)171 method modified to include an outlier 
detection technique suitable for high b-value diffusion data,175 was used to identify and replace 
motion artefacts. The fibre orientation distribution (FOD) was estimated in the corrected diffusion 
data using the constrained spherical deconvolution (CSD) method within the MRtrix package 
(https://github.com/jdtournier/mrtrix3).58, 59 MRtrix was also used to generate FA and MD maps. 
 
Voxel-based analysis of diffusion MRI 
WM microstructure between MRI data time points was interrogated using the advanced 
Normalisation Tools (ANTS)-Group-wise Voxel-based analysis, based on group-wise registration 
using the ANTS registration software.204 This analysis is similar to our previous tract-based spatial 
statistics (TBSS) analysis183 however, skeleton projection is omitted, providing greater sensitivity in 
detecting WM microstructural changes across subjects.204 Permutation testing with 5,000 iterations 
(group-wise paired t-test), correcting for multiple comparisons in space using threshold-free cluster 
enhancement was conducted using the ‘randomise’ program included in FSL.178  
 
Region of interest analysis of diffusion MRI  
WM microstructure between MRI data time points was further interrogated by creating group-wise 
FA (1) and MD (1) templates (2 total) of all serial data using whole brain voxel-wise methodology,204 
and manually selecting regions of interest (ROIs) in the medial cerebellar peduncle (MCP) and PLIC 
of these templates to represent corticomotor cerebellar and corticospinal pathways, respectively 
(Figure 5.1A). Subsequently, ROIs were projected to each patient’s FA and MD data set, to calculate 
mean FA and MD values. Time point differences of FA and MD in each ROI were statistically 
assessed using a paired t-test and visualised using the R statistical environment.192 Statistical 
significance was conferred at p<0.004 after p-value alpha adjustment for 12 multiple tests of 
hypotheses based on the number of ROIs (4) and time point comparisons (3).  
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Figure 5.1. A) Regions of interest (ROIs: depicted in red) of the left and right medial cerebellar 
peduncle (MCP) and posterior limb of the internal capsule (PLIC) are overlaid on the ataxia-
telangiectasia (A-T) patient fractional anisotropy (FA) template. B) Grey matter (GM) template of 
patient data set comparisons (time points 1 versus 2 (T1 v T2), time points 1 versus 3 (T1 v T3) and 
time points 2 versus 3 (T2 v T3), respectively) in the mid-cerebral (z-axis=39) and mid-cerebellar (z-
axis=15) plane. C) Structural T1-weighted images in the axial (first row), coronal (second row) and 
sagittal (third row) planes of an 8-year-old A-T patient brain with automated segmentation of the 
caudate, putamen, thalamus and cerebellum in cerebral and cerebellar hemispheres are presented.  
 
Voxel-based morphometry of structural MRI 
Grey matter changes between MRI data time points in A-T were analysed with FSL-Voxel Based 
Morphometry (VBM)40 an optimised protocol41 carried out with FSL tools,42 as per our previous 
analysis (4-dimensional GM templates are pictured in Figure 5.1B).183 Permutation testing with 5,000 
iterations (group-wise paired t-test), correcting for multiple comparisons in space using threshold-
free cluster enhancement178 was conducted using the ‘randomise’ program included in FSL. 
 
Volumetric analysis of deep GM structures 
To perform volumetric analysis of select deep GM areas, FMRIB's Integrated Registration and 
Segmentation Tool (FIRST), a model-based segmentation and registration tool47 was used to segment 
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the caudate, putamen and thalamus in both hemispheric locations (Figure 5.1C). Due to the sensitivity 
of the cerebellum in image resolution48 manual cerebellar segmentation was conducted, by creating 
a group-wise T1 template of all patient T1 data,204 manually selecting the cerebellum on this template 
(Figure 5.1C) and subsequently projecting the selection onto each patient T1 data set for volumetric 
computation. Time point differences in mask volume for all selected structures were statistically 
assessed using a paired t-test and visualised using the R statistical environment.192 Statistical 
significance was conferred at p<0.002 after p-value alpha adjustment for 21 multiple tests of 
hypotheses based on the number of selected structures (7) and time point comparisons (3).  
 
Results 
Baseline and serial anatomical MRI 
As shown in Figure 5.2, T1 and T2-weighted MRI scans acquired at baseline revealed heterogeneous 
patterns of cerebellar atrophy, independent of patient age. Serial T2-weighted images acquired over 
the duration of the study are also presented and show little, if any progressive cerebellar atrophy over 
this period (Figure 5.2). Ventricular enlargement, indicative of general WM degeneration, was also 
not observed (data not shown).
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Figure 5.2. A) Structural T1-weighted images of all ataxia-telangiectasia (A-T) patients at base line (time point 1) in the sagittal plane. B) Structural T2-
weighted images of the mid-cerebellar level (z-axis=5) of all A-T patients at baseline in the axial plane. C) Structural T2-weighted images of the mid-
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cerebellar level (z-axis=5) of all A-T patients at time point 2 in the axial plane. D) Structural T2-weighted images of the mid-cerebellar level (z-axis=5) 
of all A-T patients (where data was available) at time point 3 in the axial plane. 
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Neurological assessments 
Patient demographics including AT-NEST score are given in Table 5.1. Clinical observations over 
the two year period indicated heterogeneous patterns in motor dysfunction. Ataxia, movement 
disorder and communication sub-scoring were highly heterogeneous and independent of age. The A-
T NEST scores indicated marked/mixed neuropathy, with a loss of ankle, knee and bicep tendon 
reflexes and loss of proprioception in toes for 3 of the 10 patients (patients 2, 4 and 8 between time 
points 1 and 2, Table 5.1). These patients presented with a decrease in walking, standing and hand 
tapping ability over a one year time span.
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Table 5.1. Summary of A-T NEST clinical observations by time point 
Patient 
  Ataxiaa 
Movement 
Disorderb Communicationc 
  
Walking  Standing  Hand Tapping  Articulation  Response Time    
Age* Gender T1  T2  T3  T1  T2  T3  T1  T2  T3  T1  T2  T3  T1  T2  T3  
1 16 M 0 0 
  
0 0 
  
2   
  
0 0(3) 
  
0 0 
  
2 7 F 6 1 4 4 3 2 2 1 2 1 
3 12 F 1(5) 1 2(5) 0 N/A 2 0 2   1 
4 9 M 4 1 4(7) 1 1 2 1 0 1 1 
5 6 M 4(5) 5 4(5) 6(7) N/A 2 1 1 
  
1 
6 9 M 3(5) 1 1 2(5) 2(7) 0 N/A 2 2 0 1 0 1 1 
7 14 F 1(5) 0 0 1(5) 0 0 N/A 1 2 0 1 0 1 1 
8 7 F 5 3 2 4 5 3 3 3 2 2 1(3) 1(3) 1 1 1 
9 8 F 2 2 1 2 2 0 2 2 1 1 1(3) 1(3) 0 1 1 
10 10 F 4 4   3 4   2 2   1 1   1 1   
 
a Maximum score for each subcategory is 6. 
b Maximum score for each subcategory is 5. 
c Maximum score for each subcategory is 2. 
‘()’ Corresponds to a change of maximum score in the clinical assessment at the given time point juncture.  
‘T1-T3’ corresponds to time points 1-3. 
‘N/A’ corresponds to data that was collected in a different format to the listed clinical activity. 
*Age is listed at the time of the first MRI scan (T1).  
Grey fill corresponds to the absence of clinical scores. 
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WM microstructural changes 
Group-wise analyses of registered FA and MD maps employing an optimised voxel-based 
approach204 across time points revealed no significant whole brain changes in anisotropy measures, 
after correction for multiple comparisons. No significant differences in FA or MD measures in MCP 
and PLIC ROIs were observed between any time point after correction for multiple comparisons. 
Anisotropy measures for the MCP and PLIC ROI analysis are given in Table 5.2. 
 
Table 5.2. Summary statistics of Volumetric and White Matter Microstructural Analysis 
Area Hemisphere Time Point 
Mean 
Volume 
(mm3) 
SD SE 
p 
value 
Time point 
Comparison 
Cerebellum 
W 
1 106693.37 13892.87 3587.12 0.76 1v2 
 2 106379.98 14100.63 3640.77 0.88 2v3 
 3 106154.86 12772.47 4039.01 0.91 1v3 
Caudate L 1 3331.11 689.89 178.13 0.30 1v2 
 L 2 3278.65 756.50 195.33 0.03 2v3 
 L 3 3497.88 434.80 137.50 0.01 1v3 
 R 1 3590.44 736.76 190.23 0.82 1v2 
 R 2 3576.88 887.30 229.10 0.54 2v3 
 R 3 3788.89 582.65 184.25 0.39 1v3 
 
W 
1 6921.55 1412.79 364.78 0.52 1v2 
 2 6855.54 1622.74 418.99 0.21 2v3 
 3 7286.77 995.14 314.69 0.12 1v3 
Putamen L 1 4145.85 1089.51 281.31 0.75 1v2 
 L 2 4219.66 1075.62 277.72 0.32 2v3 
 L 3 4134.40 807.59 255.38 0.80 1v3 
 R 1 4084.15 986.07 254.60 0.06 1v2 
 R 2 4350.66 1016.60 262.48 0.19 2v3 
 R 3 4334.96 611.32 193.32 0.09 1v3 
 
W 
1 8229.99 2053.12 530.11 0.18 1v2 
 2 8570.33 2086.09 538.63 0.27 2v3 
 3 8469.37 1409.03 445.57 0.08 1v3 
Thalamus L 1 6206.55 1050.24 271.17 0.07 1v2 
 L 2 6363.87 1153.97 297.96 0.40 2v3 
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 L 3 6692.96 509.36 161.07 0.03 1v3 
 R 1 6023.06 1016.84 262.55 0.62 1v2 
 R 2 6011.90 1063.06 274.48 0.12 2v3 
 R 3 6473.90 417.37 131.98 0.18 1v3 
 
W 
1 12229.61 2051.74 529.76 0.38 1v2 
 2 12375.77 2204.62 569.23 0.18 2v3 
 3 13166.86 908.50 287.29 0.08 1v3 
ROI Hemisphere Time Point Mean FA SD SE 
p 
value 
Time point 
Comparison 
MCP L 1 0.48 0.03 0.01 0.92 1v2 
 L 2 0.48 0.04 0.01 0.05 2v3 
 L 3 0.51 0.01 0.00 0.01 1v3 
 R 1 0.49 0.04 0.01 0.12 1v2 
 R 2 0.51 0.04 0.01 0.99 2v3 
 R 3 0.50 0.03 0.01 0.24 1v3 
PLIC L 1 0.51 0.02 0.01 0.87 1v2 
 L 2 0.51 0.03 0.01 0.21 2v3 
 L 3 0.47 0.04 0.01 0.04 1v3 
 R 1 0.51 0.02 0.00 0.82 1v2 
 R 2 0.50 0.03 0.01 0.75 2v3 
 R 3 0.49 0.04 0.01 0.15 1v3 
ROI Hemisphere Time Point 
Mean MD 
(mm2/s) 
SD SE 
p 
value 
Time point 
Comparison 
MCP L 1 0.001 0.000 0.000 0.827 1v2 
 L 2 0.001 0.000 0.000 0.022 2v3 
 L 3 0.000 0.000 0.000 0.050 1v3 
 R 1 0.001 0.000 0.000 0.298 1v2 
 R 2 0.000 0.000 0.000 0.565 2v3 
 R 3 0.000 0.000 0.000 0.097 1v3 
PLIC L 1 0.001 0.000 0.000 0.080 1v2 
 L 2 0.001 0.000 0.000 0.154 2v3 
 L 3 0.000 0.000 0.000 0.099 1v3 
 R 1 0.001 0.000 0.000 0.030 1v2 
 R 2 0.001 0.000 0.000 0.236 2v3 
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 R 3 0.000 0.000 0.000 0.107 1v3 
 
‘FA’ corresponds to Fractional Anisotropy. 
‘L’ corresponds to Left Hemisphere.  
‘MCP’ refers to Medial Cerebellar Peduncle. 
‘MD’ corresponds to Mean Diffusivity. 
‘PLIC’ refers to Posterior Limb of the Internal Capsule.  
‘R’ corresponds to Right Hemisphere. 
‘ROI’ corresponds to Region of Interest.  
‘SD’ refers to Standard Deviation.  
‘SE’ refers to Standard Error of the Mean.  
‘v’ refers to ‘Versus’.  
‘W’ corresponds to the whole brain structure without hemispheric separation. 
  
GM volumetric changes 
Group-wise analyses of registered cortical and subcortical GM regions on structural MRI revealed no 
significant whole brain GM changes. Volumetric measures for the thalamus, basal ganglia striatum 
and cerebellum for the three time points are listed in Table 5.2. No significant change in volume of 
these structures were found over the studied two year period, after correction for multiple 
comparisons.  
 
Discussion  
Radiological MRI assessment of children with A-T has established heterogeneous patterns of 
cerebellar atrophy independent of age (reviewed in Sahama15). In a previous study comparing A-T 
and age-matched typically developing children, we have shown that degeneration is not confined to 
the cerebellum, but involves atrophy of cortical motor regions and loss in white matter integrity within 
the anterior/posterior horns of the medulla, cerebral peduncles and PLIC.183 To date, very little is 
known about progressive neurodegenerative disease in young A-T patients. With the development of 
new neuroprotective and neural-restorative therapies for A-T,205, 206 it is important to understand the 
pattern and magnitude of neurodegenerative processes to gauge the best window of opportunity for 
therapy administration.  
 
Despite clear patterns of cerebellar atrophy in our young A-T cohort, rigorous voxel-wise and ROI 
analyses of WM integrity in corticomotor cerebellar and corticospinal pathways and volumetric 
analysis of the thalamus, basal ganglia and cerebellum in the youngest patients (6 years of age), 
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revealed very little, if any, degeneration as a whole, over a period of two years. This finding was 
surprising given the established, and in some cases, significant atrophy present in baseline images. In 
terms of clinical measures, three of the ten patients showed marked reduction in clinical motor 
performance scores, however the small number of subjects precluded any statistical analysis within 
this subgroup of patients. The presence of progressive cerebellar atrophy is minimal, and reflects the 
findings of the voxel-wise and ROI analyses.  
 
The lack of significant A-T neurodegeneration in this young cohort over a two year period also leads 
to interesting questions regarding the timing of degenerative onset associated with mutation of the 
ATM gene. Extensive cerebellar atrophy is present in our youngest patients, however little, if any, 
degeneration is observed or quantitatively measurable using MRI for a follow-up period of two years. 
It may be speculated that for some patients, significant cerebellar degeneration must occur well before 
5 years of age. Clearly not only the anatomical pattern, but the magnitude and rate of 
neurodegeneration is also highly heterogeneous in patients with A-T. Acquiring MRI data from very 
young age at clinical diagnosis (2 years of age in our A-T clinics) to chronic disease state presents 
many challenges. Collaborative studies across multiple research sites182 are urgently required to 
achieve this goal. 
 
There are a number of limitations in this study, the first being the prevalence of involuntary head 
motion artefact during non-sedated MRI scanning of patients. For the analysis of dMRI data, we 
implemented an automated robust pre-processing pipeline to detect and correct for image artefacts 
caused by head motion and image distortions. Automated analysis and careful manual cross-checking 
of all deep GM and cerebellar structural volumes were also conducted to ensure a high level of 
accuracy in these measures. 
 
The A-T NEST clinical scoring system was employed in this serial study to assess clinical functional 
measures. The limitation of this system is the incomplete status of clinical tasks during patient 
examination, which provides a difficult tracking medium for neurodegeneration. To date, the A-T 
NEST scoring system is under development and has yet to be used in large A-T clinical studies with 
other clinical ataxic measures. 
 
Further study limitations include the restricted size and age range of the patient cohort and the 
investigated time period that did not allow the very early developmental sequence of A-T 
neurodegeneration from clinical diagnosis to be observed. It should be noted that in Australia, there 
are fewer than 50 cases of A-T overall, with our clinic being the only research clinic nationally, 
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specialising in health care for an estimated 54% of the Australian A-T population (children and young 
adults) overall. 
 
Trajectories of normal development for cortical and subcortical structures from typically developing 
children for comparison with A-T patients over this time frame would have been beneficial. In 
typically developing children over this age range, increased microstructural development (increased 
FA and decreased MD) within WM motor pathways202, 207, 208 with concomitant increase in cortical 
and subcortical volumes209-211 are reported. These trends were not reflected in our A-T cohort, 
indicating a complex mechanism involving compromised neurodevelopment and slow degeneration 
of WM and GM motor regions.  
 
In conclusion, this study has revealed that within a cohort of young A-T patients with well-established 
patterns of cerebellar atrophy in MRI at baseline, progressive degeneration of thalamic, cerebellar, 
basal ganglia regions and corticomotor cerebellar WM microstructural changes occur at a surprisingly 
slow rate. This finding has implications for the initiation of potential new neuroprotective and neural-
restorative therapies at the earliest stages before significant neurodegeneration has occurred in A-T 
patients. 
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CHAPTER 6 
 
Discussion and Conclusions 
 
Novel Contributions 
A series of novel developments have been made in this thesis in the purpose of applying high-
resolution MRI and diffusion-weighted imaging modalities to analyse the structural integrity of whole 
brain WM and GM structure, and corticomotor WM pathways in young A-T patients. The three aims 
of this thesis, which were to: 
 
1. assess whole brain cortex and subcortical WM and GM morphological changes between A-T 
patients and typically developing participants  
 
2. investigate if A-T neuropathy is localised to the cerebellum or extends to the entire motor 
cortex in select WM pathways in A-T  
 
3. investigate if A-T neuropathy is localised to the cerebellum or extends to the entire motor 
cortex in serial study of patients 
 
were addressed in a series of four scientific papers. The initial review paper (Chapter 2) was integral 
to the project in that it defined knowledge gaps in MRI imaging modalities in A-T. The second 
publication (Chapter 3) allowed key areas of neurodegeneration in A-T, namely the cerebral motor 
cortex and cerebellum, to be specified from anatomical and histopathological information highlighted 
in the review paper. These anatomical specifications and the whole brain imaging findings of the A-
T cohort in Chapter 3 drove further specification of key corticomotor-cerebellar WM pathways that 
connect the cerebral motor cortex and cerebellum in A-T patients in the third publication featured in 
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Chapter 4. The comprehensive WM microstructure analysis of the aforementioned pathways in 
Chapter 4 indicated that the neurodegenerative effect among young A-T patients in this study is large, 
and that multiple areas ranging from the parietal cortex (precentral and postcentral gyrus), to the 
cerebellar peduncles (for corticomotor cerebellar pathways) and spinal cord (for corticospinal 
pathways), were involved in A-T neurodegeneration. Finally in Chapter 5, structural and diffusion-
weighted MRI imaging were applied to map serial WM microstructure and GM volumetric changes 
of select corticomotor-cerebellar ROIs defined in Chapter 4. Longitudinal degeneration of thalamic, 
cerebellar, basal ganglia regions and corticomotor cerebellar WM microstructure changes were not 
found among the young A-T cohort over the studied time period however, well-established patterns 
of cerebellar atrophy in MRI at baseline were observed, indicating slow degeneration among patients, 
and the potential for new neuroprotective and neural-restorative therapies at the earliest stages of A-
T neurodegeneration.  
 
Future work  
Spinal Cord studies 
Histopathological spinal cord studies among A-T patients are limited to post-mortem study, typically 
at the end stages of disease (reviewed in Sahama15 (Chapter 2)), whereas imaging studies of the A-T 
spinal cord are limited to morphological T1 and T2-weighted structural imaging. In future, studies 
utilising dMRI and probabilistic tractography methods need to be conducted in A-T to visualise the 
extent of spinal cord WM microstructure degeneration among patients at early and advanced disease 
states. Indeed, the use of spinal cord imaging modalities have been attempted in cervical spinal cord 
studies in healthy adult populations,212-214 yielding largely reproducible results for DTI metrics. In 
addition, DTI metrics can also be determined at specific cervical cord levels (i.e. C3-C7) and 
correlated to clinical motor and sensory functions using appropriate clinical rating systems213 to 
comprehensively analyse WM microstructure, similar to tract segmentation and quantitative DTI 
measurement conducted in Chapter 4 of this thesis.  
  
International collaborative studies 
A general limitation of this project was the small number of A-T participants to undergo analysis and 
impact on the findings. In Australia, there have been fewer than 50 cases of A-T reported overall,181 
with the clinical population used in Chapters 3-5 of this thesis recruited from the only research clinic 
nationally, specialising in health care for an estimated 54% of the national population of patients. To 
understand and explore the extent of multiple affected areas of the brain and their sequence of 
development in early and advanced A-T, larger collaborative studies across multiple research sites182 
is required.  
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Animal studies 
In this project, older A-T patients (above 22 years of age) were not available for study. In this respect, 
animal models can be used to observe advanced disease states and chronic pathology in A-T. An 
established A-T mouse model has been used previously in A-T studies however, neurodegeneration 
is largely absent in this model (reviewed in Lavin215). In contrast, a novel A-T rat model, developed 
by Prof. Martin Lavin from the University of Queensland Centre for Clinical Research, provides a 
feasible medium to study the advanced stages of A-T neurodegeneration. Initial investigation of 
structural T1 images in three rat model strains (ATM gene Knock Out (ATM KO, representing the 
classic A-T phenotype), ATM gene missense mutated (representing the variant A-T phenotype with 
milder neurological symptoms than classic A-T) and wild type Fisher F344 background rat 
phenotype) revealed marked atrophy of the molecular cell layer and deep cerebellar layer of the ATM 
KO strain compared to the control (Figure 6.1). The cerebellum of the ATM missense mutated animal 
was visually similar to the control, reflecting the milder phenotype of the ATM missense mutated 
strain compared to the ATM KO strain (Figure 6.1). 
 
Figure 6.1. Axial mid-cerebellar T1 structural images of control, ataxia-telangiectasia mutated gene 
knock out (ATM KO) and ATM missense mutated rat strains. Images were taken at mid-cerebellar 
level to illustrate molecular cell layers and deep cerebellar layers of the pictured animals and atrophy 
observed in these layers (arrows).  
 
In future, whole brain analysis and probabilistic tractography analysis of the corticomotor-cerebellar 
and corticospinal pathways should be conducted in the animal model (rats) to comprehensively 
observe chronic A-T neurodegeneration in the absence of older A-T patients for study.  
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Other imaging studies 
High-resolution T1 structural images 
Despite the use of comprehensive pre-processing protocols to detect and correct for motion artefact 
in raw diffusion MRI images in A-T, improved image quality and subsequently, improved grey and 
white matter contrast in structural MRI images enable detailed analysis of A-T neurodegeneration 
using structural and volumetric analyses (i.e. cortical segmentation and VBM), and delineation of 
neural pathways using probabilistic tractography based methods. In this project, MPRAGE imaging 
sequences were used to collect high-resolution T1 structural images of A-T patients (Chapters 3-5). 
The MPRAGE sequence provides superior grey and white matter contrast and image quality than T1-
weighted spin-echo sequences,216 which were also used in this project.  
 
Recently, a modification of the MPRAGE sequence to provide better image quality in T1 structural 
data has given rise to the MP2RAGE imaging sequence.217 The MP2RAGE sequence will prove 
useful in imaging studies in A-T patients due to improved reproducibility and tissue contrast in deep 
GM regions compared to MPRAGE T1 structural images.218 Segmentation of key deep grey matter 
areas of interest in A-T, namely the caudate, putamen (striatum of the basal ganglia) and grey matter 
regions of the thalamus have been found to be significantly larger in MP2RAGE than in MPRAGE 
structural images,218 indicating the superior contrast of deep GM structures afforded by the 
MP2RAGE acquisition protocol. In addition, a quantitative high-resolution T1 map is also acquired 
in the MP2RAGE image acquisition process218 that can be used for quantitative morphometric 
neuroimaging.219 Specifically, this map can be superimposed on target brain regions in A-T220 to 
provide markers of subtle microstructural damage.221 This feature of the MP2RAGE imaging 
sequence adds further viability to distinguishing ROIs for volumetric analysis in the A-T brain 
(Chapter 5), despite poor image quality and the difficulty with which to isolate these structures 
manually from A-T brain images. It should be noted however that there is preferential bias for ROI 
selection in MP2RAGE images when selecting ROIs in the averaged T1 map,218 therefore this 
limitation should be considered when distinguishing GM areas using MP2RAGE in future A-T study. 
Lastly, MP2RAGE sequences in A-T can also be used to capture GM pathology in the spinal cord, a 
key aspect of the A-T neurodegenerative phenotype (reviewed in Sahama15 (Chapter 2)).  
 
Positron Emission Tomography  
Positron Emission Tomography (PET) is a non-invasive imaging modality that uses systemically 
administered tracers labelled with positron emitting isotopes in brain imaging.222, 223 PET imaging 
has been used in a number of neurodegenerative conditions such as cerebellar ataxia224 and 
spinocerebellar ataxia.225-227 In recent years, PET has been extended to the study of A-T, through 
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general patient work-up228 and through PET and 18F-fluorodeoxyglucose (FDG) use where brain 
glucose metabolism, a marker of brain function, was measured in ten adult A-T patients. This study 
uncovered lower glucose metabolism in the A-T cerebellum compared to controls and asymptomatic 
relatives (siblings), and significant inter-subject metabolic variability in the cerebellar vermis and 
brain.194 These findings reflect cerebellar pathology that has been reported in histopathological A-T 
studies (reviewed in Sahama15 (Chapter 2)) as well as the extensive heterogeneity of A-T 
neurodegeneration and clinical presentation, as seen in the A-T cohort used for this project.  
 
Despite the advances in A-T neuroimaging presented in the aforementioned paper, MRI imaging was 
excluded from this study due to poor image quality and unsuitability for coregistration purposes.194 
The work highlighted in this thesis has utilised a robust analysis pipeline to acquire MRI images and 
conduct dMRI analyses to interrogate neurodegeneration in A-T patients comprehensively, thus 
future use of conjoint structural MRI, dMRI and PET studies in A-T is an attractive option to 
effectively analyse key areas of neurodegeneration among A-T patients. Indeed, in spinocerebellar 
ataxia case studies, the use of MRI volumetry and multitracer PET studies have been used to identify 
metabolic and atrophic brain changes in patients,229 as well as presymptomatic markers of 
neurodegeneration, particularly in regards to striatal-dopaminergic dysfunction in patients.225 The use 
of PET-MR hybrid modalities allow the imaging of PET tracers, MRI contrast agents or MRI-
detectable metabolites in correlation to the anatomy, as well as providing improved soft-tissue 
contrast and reduced ionising radiation levels compared to PET-CT modalities,230-232 therefore the 
use of PET-MR imaging would prove useful in a radiosensitive cohort such as A-T. 
 
The involvement of dopaminergic-striatal systems have been described in A-T. From an imaging 
perspective, decreased bilateral binding of the cerebral dopamine-D2-receptor in the striatum of the 
basal ganglia has been recorded in a young A-T patient using single-photon emission computed 
tomography.233 The use of PET imaging would be useful in confirming this finding in the A-T cohort 
used in this project. In particular, the demonstrated sensitivity of PET imaging in effectively detecting 
early neuronal impairment, such as reduced postsynaptic dopaminergic levels in unaffected mutation 
carriers of ataxia,225 and before preclinical stages of neurodegenerative disease,234, 235 as well as 
highlighting cerebellar metabolic changes in asymptomatic individuals229 or genetic carriers194 of A-
T could prove useful. Underlying pathophysiological mechanisms specific to A-T can also be 
effectively pinpointed by sensitive PET analysis of dopaminergic functions,236, 237 and can also be 
used in conjunction with robust clinical rating scales225, 238 and clinical tasks239 to effectively correlate 
clinical severity with functional impairment among patients.  
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PET imaging can also be used in clinical trials to assess activation and deactivation patterns in the 
cerebral motor cortex and cerebellum, to understand motor performance changes with treatment 
among A-T patients. This methodology has been attempted in young children with cerebral palsy to 
assess the safety and efficacy of therapeutic allogeneic umbilical cord blood potentiated with 
recombinant human erythropoietin, in improving motor and cognitive dysfunction among patients,240 
and also in Multiple-System-Atrophy Parkinson-type patients, in assessing the efficacy of the 
antibiotic minocycline, in reducing the progression of neurodegeneration among patients.241 A recent 
development in A-T drug discovery highlights the use of encapsulated dexamethasone sodium 
phosphate (DSP) in autologous erythrocytes (EryDex) among A-T patients, which is devoid of the 
characteristic long-term steroid side effects and allows for slow release of dexamethasone for up to 
one month after initial dosing.205, 206 The recently conducted EryDex trial in A-T assessed the effect 
of the drug in improving A-T neurological symptoms and adaptive behaviour among patients 
however, concurrent tracking of neurological improvement among patients using imaging modalities 
was largely absent. PET imaging in this trial could contribute to a better understanding of the 
neurological improvement at the cortical motor level in the A-T brain. It should be noted that although 
PET imaging has been used among young patients in clinical pilot studies,228 PET poses a significant 
radioactive risk in A-T patients (reviewed in Sahama15 (Chapter 2)), therefore to manage this risk, 
PET studies in A-T should be attempted in adult patients.  
 
Functional MRI  
The use of functional MRI (fMRI) in analysing motor performance changes during therapeutic 
treatment in A-T (i.e. EryDex trial), could provide further insights into the neurological improvements 
of young A-T patients, without exposure to ionising radiation. fMRI was first used in A-T to track 
motor performance changes caused by Betamethasone among patients.133 In this study, six A-T 
patients received a 10-day cycle of oral betamethasone and fMRI analysis was conducted over the 
course of the study. Voxel-based comparisons were used to highlight an increase in the number of 
activated motor cortex voxels under the on-therapy condition compared with cortical activity under 
baseline conditions in patients. Changes in motor performance in treated A-T patients correlated with 
an increase in activation of relevant cortical areas, indicating motor performance improvement with 
betamethasone treatment.133 fMRI modalities have also been used in Friedrich’s ataxia and 
spinocerebellar ataxia to assess cerebellar cortex and nuclei function242 and assess the functional re-
organisation of cortical and sub-cortical brain regions, specifically the cortico-cerebellar,243-245 
cortico-striatal and parieto-frontal loops, arising from cerebellar pathology.244 Future clinical trials in 
A-T should implement fMRI analyses to map the functional re-organisation of cortico-cerebellar and 
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corticospinal pathways, to track neurological improvements with continued use of therapeutic 
compounds in young A-T patients. 
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Table 2.2. Summary of CT/MRI studies in A-T (not included in Chapter 2) 
Reference Image type 
(CT/T1/T2/MRI) 
Age Range (years) 
 
Gender 
(M/F) 
Major findings 
Chatterjee and 
colleagues(246) 
MRI 3 1/0 Findings: MRI shows a suprasellar tumour. 
Hoche and colleagues(193) MRI 4.35/14.02^ 16/6 Aims: to examine neuropsychological changes in 
young A-T patients. 
Findings: MRI images (1.5T) were available in 14 
of 22 patients and were taken in a sedated manner. 
MRI in the younger age group (average age: 4.35) 
revealed marked cerebellar atrophy. MRI in the 
older age group (average age: 14.02) revealed 
extracerebellar atrophy. Follow-up MRI was 
available for three patients (Patients 3, 4 and 9: 
maximum age range between scans 7-12.6 years 
of age) for retrospective analysis. Individual 
progress of signal changes and cerebellar atrophy 
in these three patients were recorded. Vermian 
atrophy (Patients 3 and 4) and increased signal in 
the dentate nucleus (Patients 3 and 9), cerebral 
cortex, red nucleus, substantia nigra (Patient 3), 
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* Ages and genders of patients at examination were not explicitly stated.(247) 
^ Average ages of two age groups of patients were listed in the paper.(193) 
 
caudate nucleus, putamen and thalamus (Patient 9) 
were reported.  
Meneret and colleagues(247) MRI N/A* N/A* Findings: out of MRI data for 12 patients (14 were 
recorded in this study overall), 10 displayed mild 
to severe isolated cerebellar atrophy. Patient 6 
displayed normal MRI at 25 years of age. Patient 
13 did not display cerebellar atrophy at age 20 
however a few hyperintense T2 lesions were 
observed in the cerebral WM (genu of internal 
capsule and left superior cerebellar peduncle).  
Nagasravani and 
colleagues(248) 
MRI 9 0/1 Findings: prominent cerebellar folia with mild 
hypoplasia of the inferior cerebellar vermis. 
Nakayama and 
colleagues(249) 
MRI 12 0/1 Findings: moderate atrophy of the vermis and 
cerebellum. 
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Figure 3.4 (Chapter 3). Axial T2-weighted MRI scans of the lateral ventricle and fourth ventricle 
in numbered ataxia-telangiectasia subjects. 
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Table 4.1. (Chapter 4) Summary of A-T NEST clinical observations of A-T patients 
Patient Age Ataxia Movement Disorder  Symptomsb 
1  16 Walking: 0/6 
Standing: 0/6 
 
Bradykinesia: 2/6 
Hyperkinesia: 16/16 
Dystonia: 8/12 
Ataxia: no support required for 
sitting but slight swaying is 
present. Vertical support required 
for standing and walking.  
Movement Disorder: dystonia in 
limb posturing is present with 
either social/cognitive or motor 
activation. 
Neuropathy: ankle tendon, bicep 
tendon and knee tendon reflexes 
are absent. Proprioception in toes 
are normal. 
2 7 Walking: 6/6 
Standing: 4/6 
 
  
Bradykinesia: 3/6 
Hyperkinesia: 13/16 
Dystonia: N/A+ 
 
Ataxia: no support required for 
sitting but slight swaying is 
present. Sways when standing 
with feet together. Normal path 
width without corrective steps is 
taken with walking. 
Neuropathy: ankle tendon 
reflexes are absent. Bicep tendon 
and knee tendon reflexes are 
present. Proprioception in toes 
and vibration sense at ankles are 
present. 
3 12 Walking: 1/5 
Standing: 2+/5 
 
 
Bradykinesia: 3.5/8 
Hyperkinesia: 6/15 
Dystonia: 10/14 
 
Ataxia: sits with self-support of 
arms. Corrective steps taken when 
standing. Massive lateral support 
needed for walking.  
Movement Disorder: Retro-
Colic spasms with motor or stance 
activation are present. Head/trunk 
posturing/tilt/turn is mild at rest 
147 
and during movement/posture. 
Trunk posturing/tilt/turn is mild at 
rest and normal during 
movement/posture. 
4 9 Walking: 4/6 
Standing: 4/7  
 
Bradykinesia: 1/6 
Hyperkinesia: 10/16 
Dystonia: 7/11 
 
Ataxia: sits without support but 
sways markedly. Standing and 
walking requires no support but 
takes wide base or corrective 
stagger steps. 
Movement Disorder: at rest, 
distal/hand tremor and proximal 
(face/head/trunk) tremor is 
present.  
Neuropathy: proprioception is 
normal in toes, where movement 
sensibility is intact.  
5 7 Walking: 5/6 
Standing: 6/7 
 
Bradykinesia: 2/6 
Hyperkinesia: 10/16 
Dystonia: 7/11 
 
Ataxia: no support needed for 
sitting but displays 
slight/occasional swaying. Sways 
when standing with feet together. 
Walks at normal speed without 
support, with mild path deviations 
or corrective steps.  
Movement Disorder: at rest, 
face/head/trunk/distal limb tremor 
is present.  
6 21 N/A+ N/A+  
7 10 Walking: 1/6 
Standing: 2/7 
 
Bradykinesia: 2/6 
Hyperkinesia: 6/16 
Dystonia: 8/11 
 
Ataxia: no support needed for 
sitting but displays marked 
swaying. Standing and walking 
requires lateral support.  
Movement Disorder: tremor in 
the face/head/trunk/distal limbs 
are present with both 
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social/cognitive and motor 
activation.  
Neuropathy: ankle tendon, bicep 
tendon and knee tendon reflexes 
are absent. 
8 15 Walking: 0/6 
Standing: 0/6 
 
Bradykinesia: 1/6 
Hyperkinesia: 13/16 
Dystonia: 6/11 
 
Ataxia: no support needed for 
sitting but displays marked 
swaying. Standing and walking 
require vertical support.  
Movement Disorder: tremor in 
the face/head/trunk and dystonia 
in limb posturing is present with 
social/cognitive and motor 
activation. 
Neuropathy: ankle tendon, bicep 
tendon and knee tendon reflexes 
are absent. Proprioception in toes 
have movement sensibility intact. 
Vibration sense in ankles is 
present. 
9 7 Walking: 5/6 
Standing: 4/6 
 
Bradykinesia: 4/6 
Hyperkinesia: 10/14* 
Dystonia: 8/12 
 
Ataxia: no support needed for 
sitting but displays slight swaying. 
Sways when standing with feet 
together. Walks at normal speed 
without support, with mild path 
deviations or corrective steps.  
Movement Disorder: head and 
limb posturing is present with 
either social/cognitive or motor 
activation. 
Neuropathy: knee tendon 
reflexes are present. Ankle tendon 
reflexes are absent. 
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Proprioception in toes is not 
completely absent. 
10 22 Walking: 0/6 
Standing: 0/6 
 
Bradykinesia: 2/6 
Hyperkinesia: 8/16 
Dystonia: 3/12 
 
Ataxia: no support needed for 
sitting but displays slight swaying. 
Standing and walking requires 
vertical support.  
Movement Disorder: at rest, 
distal limb movement is present. 
Tremor in the face/head/trunk is 
present with both social/cognitive 
and motor activation. Head and 
limb posturing is present with 
both social/cognitive and motor 
activation. 
Neuropathy: ankle tendon, bicep 
tendon and knee tendon reflexes 
are absent. Some vibration sense 
at ankles is intact. 
11 8 Walking: 2/6 
Standing: 2/6 
 
Bradykinesia: 2/6 
Hyperkinesia: N/A+ 
Dystonia: N/A+ 
 
Ataxia: no support needed for 
sitting but displays marked 
swaying. No support needed for 
standing however corrective steps 
are taken. Walking requires some 
lateral support. 
12 10 Walking: 4/6 
Standing: 3+/6 
 
Bradykinesia: 2/5* 
Hyperkinesia: 11/16 
Dystonia: 6/11 
 
Ataxia: no support needed for 
sitting or standing but sways 
markedly while sitting and 
requires corrective steps when 
walking. 
Movement Disorder: Retro-
Colic spasms and distal/hand 
movement are present with either 
social/cognitive or motor or 
posture activation.  
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Neuropathy: proprioception in 
toes is present, with rare position 
errors during clinical task. Plantar 
responses are normal. 
  
* Clinical tests were incomplete. 
+ Clinical scores were absent/not recorded. 
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Table 4.2. (Chapter 4) Summary of Corticomotor Tract Diffusion Tensor Metrics 
Tract Corticospinal Cortico-Ponto-Cerebellar 
 Left Right Left Right 
Bin(%) Condition N^ FA SD# MD SD# N^ FA SD# MD SD# N^ FA SD# MD SD# N^ FA SD# MD SD# 
0 
Control 524578 0.32 0.11 0.0006 0.0001 500550 0.32 0.11 0.0006 0.0001 71044 0.31 0.10 0.0006 0.0001 87857 0.32 0.11 0.0006 0.0001 
Patient 176514 0.31 0.10 0.0006 0.0001 126239 0.32 0.10 0.0006 0.0001 98879 0.32 0.10 0.0006 0.0001 83869 0.32 0.10 0.0006 0.0001 
5 
 
Control 514884 0.43 0.10 0.0006 0.0001 491897 0.43 0.11 0.0006 0.0001 70175 0.43 0.11 0.0006 0.0001 86754 0.44 0.10 0.0006 0.0001 
Patient 179386 0.42 0.10 0.0006 0.0001 127326 0.43 0.11 0.0006 0.0001 99184 0.43 0.10 0.0006 0.0001 83791 0.44 0.09 0.0006 0.0001 
11 
 
Control 517077 0.47 0.09 0.0005 0.0000 493168 0.48 0.10 0.0005 0.0000 70223 0.47 0.11 0.0005 0.0000 86816 0.48 0.10 0.0005 0.0000 
Patient 178179 0.47 0.09 0.0005 0.0000 127663 0.49 0.09 0.0005 0.0000 98930 0.49 0.10 0.0005 0.0000 83772 0.48 0.09 0.0005 0.0000 
16 
 
Control 521351 0.47 0.10 0.0005 0.0000 497841 0.48 0.10 0.0005 0.0000 70794 0.45 0.10 0.0005 0.0000 87388 0.45 0.10 0.0005 0.0000 
Patient 178080 0.48 0.09 0.0005 0.0000 126982 0.50 0.10 0.0005 0.0000 99334 0.48 0.11 0.0005 0.0000 84205 0.47 0.10 0.0005 0.0000 
21 
 
Control 519892 0.46 0.10 0.0005 0.0000 495681 0.45 0.10 0.0005 0.0000 70559 0.42 0.10 0.0005 0.0000 87265 0.43 0.11 0.0005 0.0000 
Patient 177923 0.48 0.10 0.0005 0.0000 126956 0.49 0.10 0.0005 0.0000 99176 0.46 0.11 0.0005 0.0000 83735 0.43 0.10 0.0005 0.0000 
26 
 
Control 517905 0.48 0.11 0.0005 0.0000 494723 0.47 0.11 0.0005 0.0000 70443 0.45 0.11 0.0005 0.0001 87112 0.46 0.11 0.0005 0.0000 
Patient 178506 0.47 0.10 0.0005 0.0000 127540 0.47 0.09 0.0005 0.0000 99277 0.44 0.10 0.0005 0.0000 84152 0.43 0.10 0.0005 0.0000 
32 
 
Control 518613 0.56 0.10 0.0005 0.0000 495613 0.55 0.10 0.0005 0.0000 70486 0.51 0.11 0.0005 0.0000 87116 0.52 0.11 0.0005 0.0000 
Patient 177230 0.51 0.10 0.0005 0.0000 126529 0.51 0.10 0.0005 0.0000 98633 0.49 0.10 0.0005 0.0000 83519 0.48 0.11 0.0005 0.0000 
37 
 
Control 521073 0.62 0.08 0.0005 0.0000 497154 0.61 0.08 0.0005 0.0000 70727 0.58 0.09 0.0005 0.0000 87411 0.58 0.10 0.0005 0.0000 
Patient 178446 0.58 0.09 0.0005 0.0000 127127 0.57 0.09 0.0005 0.0000 99434 0.56 0.09 0.0005 0.0000 84122 0.56 0.09 0.0005 0.0000 
42 
 
Control 521858 0.65 0.07 0.0005 0.0000 497653 0.65 0.07 0.0005 0.0000 70888 0.62 0.08 0.0005 0.0000 87579 0.62 0.08 0.0005 0.0000 
Patient 177992 0.63 0.07 0.0005 0.0000 126885 0.62 0.07 0.0005 0.0000 99257 0.61 0.07 0.0005 0.0000 84199 0.62 0.08 0.0005 0.0000 
47 
 
Control 516949 0.67 0.07 0.0005 0.0000 493976 0.67 0.07 0.0005 0.0000 70310 0.62 0.09 0.0005 0.0000 86845 0.62 0.09 0.0005 0.0000 
Patient 178086 0.65 0.07 0.0005 0.0000 127072 0.64 0.07 0.0005 0.0000 98977 0.62 0.07 0.0005 0.0000 83584 0.63 0.08 0.0005 0.0000 
53 
 
Control 516429 0.66 0.10 0.0005 0.0000 493878 0.66 0.10 0.0005 0.0000 70179 0.59 0.10 0.0005 0.0001 86869 0.61 0.11 0.0005 0.0001 
Patient 178029 0.62 0.09 0.0005 0.0000 127437 0.61 0.09 0.0005 0.0000 98905 0.59 0.09 0.0005 0.0000 83765 0.61 0.09 0.0005 0.0000 
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58 
 
Control 521858 0.64 0.12 0.0005 0.0001 497653 0.64 0.12 0.0005 0.0001 70888 0.56 0.12 0.0006 0.0001 87579 0.59 0.13 0.0006 0.0001 
Patient 177992 0.57 0.12 0.0005 0.0001 126885 0.56 0.11 0.0005 0.0001 99257 0.54 0.11 0.0005 0.0001 84199 0.57 0.12 0.0005 0.0001 
63 
 
Control 521073 0.62 0.13 0.0006 0.0001 497152 0.60 0.13 0.0006 0.0001 70727 0.51 0.14 0.0006 0.0001 87411 0.54 0.14 0.0006 0.0001 
Patient 178438 0.52 0.13 0.0006 0.0001 127127 0.50 0.12 0.0005 0.0001 99434 0.49 0.12 0.0006 0.0001 84122 0.50 0.13 0.0006 0.0001 
68 
 
Control 517220 0.58 0.13 0.0006 0.0001 493667 0.55 0.13 0.0006 0.0001 70278 0.45 0.15 0.0006 0.0001 86898 0.45 0.15 0.0006 0.0002 
Patient 178072 0.52 0.13 0.0006 0.0001 127176 0.51 0.12 0.0005 0.0001 98864 0.49 0.13 0.0005 0.0001 83731 0.47 0.13 0.0005 0.0001 
74 
 
Control 519299 0.49 0.12 0.0005 0.0001 496665 0.50 0.12 0.0005 0.0001 70650 0.37 0.13 0.0006 0.0002 87330 0.33 0.13 0.0006 0.0002 
Patient 177594 0.50 0.12 0.0005 0.0001 126893 0.51 0.11 0.0005 0.0001 99046 0.46 0.13 0.0005 0.0001 83934 0.43 0.12 0.0005 0.0001 
79 
 
Control 519892 0.41 0.10 0.0005 0.0001 495681 0.41 0.10 0.0005 0.0001 70559 0.32 0.10 0.0006 0.0002 87265 0.29 0.09 0.0006 0.0002 
Patient 177923 0.43 0.10 0.0005 0.0001 126956 0.44 0.09 0.0005 0.0001 99176 0.38 0.11 0.0005 0.0001 83727 0.34 0.10 0.0005 0.0001 
84 
 
Control 521351 0.37 0.09 0.0005 0.0001 497841 0.36 0.09 0.0006 0.0001 70794 0.34 0.10 0.0006 0.0001 87388 0.35 0.11 0.0006 0.0001 
Patient 178080 0.36 0.08 0.0005 0.0001 126982 0.38 0.09 0.0005 0.0001 99334 0.33 0.09 0.0005 0.0001 84200 0.33 0.10 0.0005 0.0001 
89 
 
Control 518471 0.35 0.09 0.0006 0.0001 495110 0.34 0.09 0.0006 0.0001 70430 0.39 0.11 0.0005 0.0001 87028 0.39 0.13 0.0006 0.0001 
Patient 177283 0.30 0.06 0.0006 0.0001 127016 0.34 0.11 0.0006 0.0001 98699 0.34 0.08 0.0005 0.0001 83556 0.36 0.09 0.0005 0.0001 
95 
 
Control 513490 0.32 0.08 0.0007 0.0001 489955 0.31 0.09 0.0007 0.0002 69968 0.49 0.14 0.0005 0.0001 86479 0.49 0.15 0.0006 0.0002 
Patient 180281 0.28 0.07 0.0006 0.0001 127971 0.29 0.08 0.0006 0.0001 99415 0.41 0.12 0.0006 0.0001 84002 0.40 0.13 0.0006 0.0002 
100 
 
Control 524578 0.34 0.09 0.0007 0.0001 500550 0.33 0.09 0.0007 0.0001 71044 0.57 0.13 0.0005 0.0001 87857 0.57 0.13 0.0005 0.0001 
Patient 176514 0.30 0.09 0.0007 0.0002 126239 0.32 0.10 0.0007 0.0002 98879 0.50 0.14 0.0005 0.0001 83869 0.48 0.13 0.0006 0.0002 
 
^ ‘N’ refers to number of values sampled in each tract. 
# ‘SD’ refers to Standard Deviation. 
‘FA’ and ‘MD’ refers to average Fractional Anisotropy and Mean Diffusivity across all control participant/patient ages respectively. 
‘Bin(%)’ refers to percentage of tract along the length of the target pathway.  
